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ABSTRACT
Probabilistic Models for Genetic and Genomic Data with Missing Information
by
Stephanie Carinne Hicks
Genetic and genomic data often contain unobservable or missing information.
Applications of probabilistic models such as mixture models and hidden Markov
models (HMMs) have been widely used since the 1960s to make inference on un-
observed information using some observed information demonstrating the versatility
and importance of these models. Biological applications of mixture models include
gene expression data, meta-analysis, disease mapping, epidemiology and pharmacol-
ogy and applications of HMMs include gene finding, linkage analysis, phylogenetic
analysis and identifying regions of identity-by-descent. An important statistical and
informatics challenge posed by modern genetics is to understand the functional conse-
quences of genetic variation and its relation to phenotypic variation. In the analysis of
whole-exome sequencing data, predicting the impact of missense mutations on protein
function is an important factor in identifying and determining the clinical importance
of disease susceptibility mutations in the absence of independent data determining
impact on disease. In addition to the interpretation, identifying co-inherited regions
of related individuals with Mendelian disorders can further narrow the search for
disease susceptibility mutations. In this thesis, we develop two probabilistic models
in application of genetic and genomic data with missing information: 1) a mixture
model to estimate a posterior probability of functionality of missense mutations and
2) a HMM to identify co-inherited regions in the exomes of related individuals. The
first application combines functional predictions from available computational or in
silico methods which often have a high degree of disagreement leading to conflicting
results for the user to assess the pathogenic impact of missense mutations on protein
function. The second application considers extensions of a first-order HMM to include
conditional emission probabilities varying as a function of minor allele frequency and
a second-order dependence structure between observed variant calls. We apply these
models to whole-exome sequencing data and show how these models can be used
to identify disease susceptibility mutations. As disease-gene identification projects
increasingly use next-generation sequencing, the probabilistic models developed in
this thesis help identify and associate relevant disease-causing mutations with human
disorders. The purpose of this thesis is to demonstrate that probabilistic models can
contribute to more accurate and dependable inference based on genetic and genomic
data with missing information.
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1Chapter 1
Introduction
An important statistical and informatics challenge posed by modern genetics is to
understand the functional consequences of genetic variation and its relation to phe-
notypic variation. For example, in cancer genomics this broadly translates to identify-
ing cancer susceptibility mutations which can impact decisions related to prevention,
prognosis and treatment in the a↵ected patient and at-risk family members. This has
been a di cult task as human cancer is immensely complex and an increase in the
risk cancer susceptibility can result from combinations and permutations of hundreds
of genetic alterations.
Probabilistic models such as mixture models and hidden Markov models (HMMs)
are two examples of powerful statistical models which have been successfully applied
in a vast area of biological (and non biological) research. Both models make inference
on observable and unobservable (or latent) data which is often the case when using
genetic or genomic data. Mixture models are mixtures of probability distributions,
but the information about which subpopulation each observation belongs to is typ-
ically missing. These models were first introduced by Karl Pearson [Pearson, 1894]
and have been applied in a wide range of areas such as biology, economics, astronomy,
engineering. A hidden Markov model can be considered a generalization of a mixture
model where the hidden variables (or latent variables), which control the mixture
component to be selected for each observation, are related through a Markov process
rather than independent of each other. Hidden Markov models are used to model an
2underlying, unobservable process given observations emitted by the process. They
have been applied since the late 1960s and early 1970s because of the rich mathe-
matical structure that has been developed for the models [Rabiner, 1989]. The large
number of applications, including gene finding, linkage analysis, phylogenetic analysis
and identifying regions of identity-by-descent, indicate the versatility and importance
of these models.
In the advent of next-generation sequencing, obtaining data is no longer the bot-
tleneck in genomics, but rather the bottleneck is the interpretation of the genetic
alterations. In this thesis, probabilistic models in application for genetic and genomic
data with missing information will be considered: 1) mixture model to estimate the
probability of functionality of missense mutations using observed predictions from
known bioinformatics or in silico algorithms and 2) a HMM to identify co-inherited
regions in the exomes (the part of the genome formed by exons which are the coding
portions of genes) of related individuals.
In Chapter 1, a brief introduction to probabilistic models for data with missing
information, specifically mixture models and hidden Markov models, will be given fol-
lowed by a brief discussion of examples and applications. Chapter 2 begins with the
mathematical theory, methodology and specific properties of mixture models (Section
2.1), Expectation-Maximization algorithm (Section 2.2) and hidden Markov mod-
els (Section 2.3). Section 2.4 conveys basic principals in genetic mapping such as
Mendelian genetics and recombination. The genetic architecture of diseases is briefly
discussed in Section 2.5. The last two sections (2.6, 2.7) in this chapter motivate the
applications of mixture models and hidden Markov models for genetic and genomic
data formally developed in Chapter 4 and Chapter 5.
In Chapter 3, a study is given of how predictions of missense mutation functional-
3ity depend on the in silico method and sequence alignment employed. We show there
is a high degree of disagreement between the predictions of functionality produced
by these in silico methods. The material discussed in this chapter was published in
two articles in Human Mutation [Hicks et al., 2011, Hicks et al., 2013] and the former
was highlighted and discussed in Nature [Baker, 2012].
In Chapter 4, we develop a new method for interpreting the functionality of mis-
sense mutations. In Section 4.1 we discuss previously proposed solutions for combin-
ing predictions of functionality and investigate the level of agreement between these
in silico algorithms. In Section 4.2, we develop two statistical models based on the
capture-recapture paradigm which combine often discordant functional predictions
in a statistically rigorous manner and estimate a unified posterior probability for
each mutation being deleterious. Unlike previous methods, our approach, referred to
as postMUT and postMUT (simple), requires no training set or calibration and esti-
mates the sensitivity and specificity of each individual in silico method in the absence
of a gold standard by taking advantage of the fact these methods disagree. Several
applications of these models are considered in Section 4.3. When a gold standard is
available, we show the sensitivity and specificity estimates using the postMUT models
closely match the sensitivity and specificity estimated directly using the known func-
tional mutation status. As another application, we use two matched normal/tumor
breast cancer genomes and show an enrichment of deleterious mutations using muta-
tions found only in the tumor and only in the normal compared to mutations both
in the normal and tumor. These posterior probabilities may be used as a filter when
inferring the functionality of missense mutations in exome-scale sequencing projects.
In Chapter 5, we investigate the performance of the postMUT (simple) and post-
MUT models by performing simulation studies. We assess bias and mean squared
4error (MSE) as a function of the number of mutations in a given dataset.
In Chapter 6, we consider several inhomogeneous HMMs used to predict regions of
identity-by-descent (IBD) in siblings a↵ected by an autosomal recessive disease using
the identity-by-state (IBS) status observed from whole-exome sequencing data. To
improve accuracy, we extend a previously developed first-order HMM by exploring
conditional emission probabilities and a second-order dependence structure between
observed variants calls. The models are formally discussed in Section 6.3, 6.4 and
6.5. Additionally, we show the conditional emissions vary as a function of minor
allele frequency. The models are evaluated on simulated exome sequencing data and
real human exome sequencing data to identify regions of IBD in Section 6.6 and 6.7.
These models provide researchers a tool to filter large portions of the exome in search
of finding the causal variant for a given disease. We conclude with Chapter 7 and
discuss ideas for future directions.
1.1 Motivation for Probabilistic Models
1.1.1 Mixture Models
Mixture models are probabilistic models representing mixtures of distributions (or
subpopulations). Observations are considered to be drawn independently from any
subpopulation, but we do not observe which subpopulation it was drawn from. Mix-
ture models were first discussed by Karl Pearson [Pearson, 1894] and they have been
a widely studied topic since the late 1960s and 1970s [McLachlan and Peel, 2000].
Consider a random sampleX = (X1, . . . , Xn) where each observation is identically
and independently drawn from the probability distribution f(x). Each independent
observation is drawn from one of the g finite subpopulations. Let Y = (Y1, . . . , Yn)
5represent what subpopulation the ith observation was drawn from. Each Yi is a
categorical variable taking values in (1, . . . , g). A mixture model is a weighted sum
of g component densities fj(x)
f(x) =
gX
j=1
pjfj(x)
where pj are the nonnegative mixture proportions or weights which must sum to one.
0  pj  1 and
gX
j=1
⇡j = 1
↵Instead of using the likelihood directly, it is common to use the logarithm of the
likelihood of X which is given by
l(✓) = logL(✓|x) =
nX
i=1
log
gX
j=1
pjfj(xi)
Note, we can also re-write Y as Y = (Y1, . . . ,Yn) where each Yi is a g-dimensional
vector of indicator variables depending on whether jth component of Yi (i.e. Yij =
(Yi)j is equal to 1 or 0. In this case, Yi follows a a multinomial distribution with
probabilities p1, . . . pg.
There are three basic questions of when applying mixture models:
1. Are the number of components or subpopulations g considered fixed and pre-
specified before estimation or is g fixed but not necessarily known and should
be inferred from the data?
2. Are the component densities fj(xi) defined parametric, semi-parameteric or
non-parametric?
3. Given the observations X, how do we estimate the weight proportions pj and,
if applicable, the parameters ✓ in the parametric component densities fj(xi|✓)?
6These questions have all been widely studied and various solutions to all have
been provided. In this thesis we assume g is fixed and pre-specified before parame-
ter estimation. We assume our component densities fj(xi|✓) to be parametrized by
✓. Finally, parameter estimation is performed using the Expectation-Maximization
algorithm [Dempster et al., 1977].
1.1.2 Markov Models
Instead of observations being identically and independently drawn from a population
such as in Section 1.1.1, sometimes a dependence between observations is assumed.
If the past and present information is known about a particular process, then the
“Markov” property states that inference on the future depends only on the present
information. Hidden Markov models use the set of probabilistic models called Markov
processes or Markov chains that allow the probability observing a particular state be
dependent on the previous states. If the process is in continuous-time, then it is called
a Markov process or if it is in discrete-time then it is called a Markov chain. The
Markov model is characterized by a transition probability matrix P which describes
the probability of the process or chain moving from state to state.
Consider a first-order discrete-time Markov chain {Xn, n = 0, 1, 2, . . .} with
distribution P and finite state space S = {s0, s1, . . . , sN}. The first-order Markov
property states that given that process is in state si there is a given fixed probability
Pij that it will next be in state sj which only depends on the previous state (e.g.
first-order):
Pij = P [Xn+1 = sj|Xn = si]
7such that
Pij   0, i, j   0;
1X
j=0
Pij = 1, i = 0, 1, . . .
and the joint probability of the chain with length L is given by
P (X) = P [XL, XL 1, . . . , X1]
= P [XL|XL 1, . . . , X1]P [XL 1|XL 2, . . . , X1] . . . P [X1]
= P [XL|XL 1]P [XL 1|XL 2] . . . P [X1] (Markov property)
= P [X1]
LY
n=2
P [Xn|Xn 1]
A first-order continuous-time Markov process {X(t) : t   0} with a finite state
space S is a stochastic process satisfying the Markov property
P [X(t+ h) = j|X(t) = i] = qijh+ o(h), i 6= j
where qij is the i, j entry of the transition intensity matrix Q where
qii =  
X
j 6=i
qij
1.1.3 Hidden Markov Models
A hidden Markov model can be considered a generalization of a mixture model where
the hidden variables (or latent variables), which control the mixture component to
be selected for each observation, are related through a Markov process rather than
independent of each other. These models arise when the chain of interest is unob-
servable, but a di↵erent set states are observable called emissions conditional on the
unobservable state. To formalize the notation, let the unobservable Markov chain be
given by {⇡n, n = 0, 1, 2, . . .} and is characterized by the transition probabilities
Pij = P [⇡n = j|⇡n 1 = i]
8The beginning of the process is defined by the stationary distribution ai = P (⇡1 = i)
or probability of starting in state i. We do not observe the path of the chain ⇡n, but
we do observe a process {Xn, n = 0, 1, 2, . . .} with a set of states and given emission
probabilities
ej(b) = P [Xn = b|⇡n = j]
defined as the probability that we observe state b given the unobservable chain is in
state j. Then, the joint probability of the observed sequence X and unobservable
sequence ⇡ is given by
P (X, ⇡) = ai
LY
n=1
e⇡n(xn)P⇡n,⇡n 1
There are three basic questions of interest when applying HMMs:
1. Given the observed sequence X and model parameters ✓ = {P, e, a}, how do we
predict most probable path ⇡⇤ or predict which state the unobservable chain ⇡
is in given the observable states?
2. Given the observed sequence X and model parameters ✓, how do we compute
P (X|✓) or the probability of the observed sequence given the model parameters?
3. When the model parameters ✓ are unknown, how do we estimate the parameters
that maximize P (X|✓)?
These three questions have all been answered using the following algorithms:
1. If the goal is to predict which state the unobservable chain ⇡ is in given the
observable states, then we find the most probable path ⇡⇤ by computing
⇡⇤ = argmax
⇡
P (X, ⇡)
This can be computed using the Viterbi algorithm [Rabiner, 1989, Durbin et al., 1998].
92. The probability of the observed sequence X can be found by marginalizing over
the joint probability by summing over all possible hidden paths of ⇡:
P (X) =
X
⇡
P (X, ⇡)
This can be computed using the Forward algorithm [Rabiner, 1989, Durbin et al., 1998].
3. If the transition probabilities and emission probabilities are unknown, then they
can be estimated using the Baum-Welch algorithm [Rabiner, 1989, Durbin et al., 1998].
The Baum-Welch algorithm (also called the forward-backward algorithm) is an
EM algorithm commonly used to estimate the parameters in a hidden Markov
model. For details related to the estimation see [Blimes, 1998].
1.2 Biological Applications
1.2.1 Mixure Models
Karl Pearson [Pearson, 1894] was the first to use mixture models on a dataset mea-
suring the ratio of forehead to body length of n = 100 crabs [Weldon, 1893] indi-
cating the evolution of two new subspecies. At that time, parameter estimation
was performed using method of moments [Lehmann and Casella, 1998], but in the
late 1960s maximum-likelihood based approaches were introduced, in particular the
Expectation-Maximization algorithm [Dempster et al., 1977] which significantly in-
creased the use of mixture models.
Over the past 40-50 years, mixture models have been successfully applied in a
diverse range of fields. In medical applications, mixture models have been commonly
employed in gene expression data, disease mapping, drug development, and meta-
analyses [Schlattmann, 2009].
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In the analysis of gene expression data, mixture models are used to find di↵er-
ences in gene expression levels between subgroups of individuals [Lee et al., 2000,
Efron et al., 2001, McLachlan et al., 2006]. The most basic model assumes a two-
component mixture model where the gene is either being di↵erentially expressed or
nondi↵erentially expressed. Ultimately, this could lead to individualized therapy on
the basis of gene expression in the tumor cells such as breast cancer [Brennan et al., 2007].
Disease mapping or investigating the geographical distribution of disease occur-
rence through the use of mixture models has been studied for over three decades
[Schlattmann and Bo¨hning, 1993] in applications such as malaria [Rattanasiri et al., 2004]
and breast cancer [Schlattmann, 2000]. In meta-analyses, covariate-adjusted mixture
models have been introduced in metaregression [Schlattmann, 2000] where the het-
erogeneity between studies is explained by covariates in finite mixture models. This is
beneficial because it alleviates the assumption of a normal distribution of the random
e↵ects in the usual random e↵ects model. For the analysis of microarrays, bayesian
mixture models have been frequently used in meta-analyses [Conlon, 2008].
Many software packages and tools have been implemented to ease the compu-
tational burden. Within R [R Core Team, 2012], there are over 50 packages listed
related to cluster analysis and finite mixture models under the CRAN task view
(http://cran.r-project.org/web/views/Cluster.html). Both maximum-likelihood and
bayesian approaches have been widely implemented in various R packages. Some pop-
ular mixture models include mixtools [Benaglia et al., 2009] and mclust [Fraley and Raftery, 2012].
Other programming languages which have implemented tools for mixture models in-
clude MATLAB, SAS, Python. A few commonly used standalone free packages for es-
timation of mixture models include DispapWin for disease mapping [Schlattmann, 1996]
and EMMIX for the fitting of mixtures of normal and t-components [McLachlan et al., 1999].
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Other non-biological applications of mixture models include speaker identification
[Reynolds and Rose, 1995], image analysis [Permuter et al., 2003], and economics
[Brigo and Mercurio, 2002].
1.2.2 Hidden Markov Models
The most successful applications of hidden Markov models in computational bi-
ology and bioinformatics have been profile HMMs and HMM-based gene finders
[Eddy, 1998]. Profile HMMs were introduced in 1994 [Krogh et al., 1994a] allow-
ing a multiple sequence alignment to be converted into a position-specific scoring
system ultimately allowing databases to be searched for homologous sequences. In
general, each column in the sequence alignment is modeled as a ‘match state’, ‘in-
sert state’, both having 4 or 20 nucleotide or amino acid emission probabilities
each, and a ‘delete state’, with no emission probabilities. Several profile HMM soft-
ware packages exist: SAM [Hughey and Krogh, 1996, Karplus et al., 1998], HMMER
[Eddy, 1998], PFTOOLS [Bucher et al., 1996], and HHMPro [Baldi et al., 1994]. Ex-
amples of profile HMM libraries include PROSITE profiles [Sigrist et al., 2010] and
Pfam [Finn et al., 2010].
Gene finding or gene prediction is defined as identifying regions of genomic DNA
that encode genes from a given sequence. The two main types of gene finders are ab
initio and homology-based (or similarity-based). A third class of hybrids also exists.
Given the observed nucleotide sequence, the HMM assigns ‘classes’ to each position
such as exons, introns, Poly(A) tails, and TATA boxes [Knapp and Chen, 2007] which
identifies genes. Many HMM-based gene finders have been developed with varying lev-
els of accuracy. A review of existing methods [Mathe´ et al., 2002, Wang et al., 2004]
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tus, Genezilla, GenomeScan, GlimmerHMM, SNAP and Twinscan) have been per-
formed. Applications of HMM-based gene finders have existed since the early 1990s
[Krogh et al., 1994b, Kulp et al., 1996, Burge and Karlin, 1997, Henderson et al., 1997,
Krogh, 1997, Lukashin and Borodovsky, 1998].
CpG islands [Bird, 1987] are made up of a few hundred to a few thousand repeat
CG dinucleotides. Identifying CpG islands in a given stretch of genomic sequence is
biologically important because it can be an indication of the promoter region of a
gene, which in turn helps locate genes across a long stretch genomic sequence. Given
an observed CG dinucleotide, the hidden states are defined as island states and non-
island states where the nucleotides C+ and G+ represent the islands states and C 
and G  represent the non-islands states. Hidden Markov models have been applied
to identify the switching between islands and non-islands states [Durbin et al., 1998].
Another area that HMMs have been successfully applied is the prediction of pro-
tein secondary structure. Predictions from a single protein sequence [Asai et al., 1993,
Stultz et al., 1993, Goldman et al., 1996] are based on the idea that certain types of
amino acids were associated with certain secondary structure environments
[Balding et al., 2007]. Likelihoods associated with HMMs of protein structure have
been applied to DNA sequence data [Churchill, 1989] and are explained in detail
[Thorne et al., 1996].
Other biological applications of HMMs include pairwise sequence alignments
[Durbin et al., 1998], phylogenetic analysis [Felsenstein, 1981, Felsenstein and Churchill, 1996,
Thorne et al., 1996], genetic linkage mapping [Lander and Green, 1987, Kruglyak et al., 1996],
identifying regions of identity-by-descent which will be discussed in Chapter 2. Non-
biological applications include speech recognition [Ramesh and Wilpon, 1992] and
[Watson and Chung Tsoi, 1992, Rabiner, 1989, Zelinka and Sigmund, 2010], ecology
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[Guttorp, 1995], image analysis [Romberg et al., 2001], economics [Hamilton, 1989,
Albert and Chib, 1993] and music analysis [Qi et al., 2007].
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Chapter 2
Background
2.1 Mixture Models
In Chapter 1, we introduced the idea of mixture models. In this section, we will
formalize the notation. Suppose we have a random sample X = (X1, . . . , Xn) in-
dependently and identically distributed f(x|✓) and parameterized by ✓. The the
likelihood L(✓|X) is interpreted as a function of the parameters where the data is
fixed.
L(✓|X) =
nY
i=1
f(xi|✓)
In the maximum likelihood framework, our goal is to find the ✓ which maximizes L
or find
✓⇤ = argmax
✓
L(✓|X)
To find the maximum likelihood estimate (MLE), we compute the gradient of the log
likelihood log(L(✓|X)), set equal to 0 and solve for ✓. Let ✓ˆ be the MLE of ✓.
When we are not able to observe the entire data set because it contains missing
values or is incomplete, then other statistical estimation techniques besides maximum-
likelihood esimateion should be employed. In Chapter 1, we previously considered
a random sample X = (X1, . . . , Xn) where each observation is identically and inde-
pendently drawn from the probability distribution f(x). Let f(x) be a parametric
probability distribution f(x|✓). Each independent observation is drawn from one of
the g finite subpopulations. Let Y = (Y1, . . . , Yn) represent what subpopulation the
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ith observation was drawn from. Each Yi is a categorical variable taking values in
1, . . . , g. Therefore, if we assume Xi is drawn from the jth subpopulation (i.e. Yi = j)
with probability distribution fj(x|✓), we can write
f(x|✓) =
gX
j=1
pjfj(x|✓)
where pj are the nonnegative mixture proportions or weights which must sum to one:
0  pj  1 and
gX
j=1
⇡j = 1
Because we do not observe which subpopulation the ith observation was drawn from,
we cannot compute the MLE directly.
2.2 Expectation-Maximization Algorithm
The Expectation-Maximization algorithm is a method of finding the maximum-likelihood
estimate of the parameters of an underlying distribution from a given data set when
the data is incomplete or has missing values [Blimes, 1998]. Let X = (X1, . . . , Xn) be
the incomplete data or observed data. Let Y = (Y1, . . . , Yn) be the augmented data
we do not observe because it is missing. We define Z = (X,Y) as the complete data
and
f(z|✓) = f(x,y|✓) = f(x|y, ✓)f(y|✓)
and the marginal distribution of X is given by
f(x|✓) =
Z
f(x,y|✓)dy
We define L(✓|x) = f(x|✓) as the incomplete-data likelihood and L(✓|x,y) = f(x,y|✓)
as the complete-data likelihood. Technically speaking, Y is considered unknown and
random and we can think of L(✓|x,Y) as a function of a random variable Y where x
is constant.
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In the EM algorithm, we want to maximize L(✓|x,Y) in ✓, but we do this using
a conditional expectation
Q(✓|✓(t)) = EY|x,✓(t) [logL(✓|x,Y)]
where ✓(t) is the parameter estimate for ✓ at the previous tth iteration which we use to
evaluate the expectation. The EM algorithm moves in iterations between two steps:
The Expectation Step (E-Step) and the Maximization Step (M-Step).
2.2.1 Estimation Steps
E-Step
Take the expectation of the complete-data likelihood with respect to Y conditional
on the observed data x and the current parameter estimates ✓(t)
Q(✓|✓(t)) = EY|x,✓(t) [logL(✓|x,Y)] =
Z
log f(y,x|✓)f(y|x, ✓(t))dy
where f(y|x, ✓(t)) is the marginal distribution of the unobserved or missing data
[Dempster et al., 1977, Blimes, 1998].
M-Step
Find the new ✓(t+1) that maximizes Q(✓|✓(t))
✓(t+1) = argmax
✓
Q(✓|✓(t))
where ✓ represents the set of parameters we are searching for to maximize the likeli-
hood and ✓(t) are the estimated parameters at the previous iteration and will be used
to evaluate the expectation [Dempster et al., 1977, Blimes, 1998].
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2.2.2 Monotonicity of EM algorithm
As the EM algorithm iterates between the E-Step and M-Step, the goal is to maximize
L(✓|x) by working with only L(✓|x,y) and f(y|x, ✓(t)). With an initial guess ✓(0),
the EM algorithm will ‘improve’ and converge to a local maximum of logL(✓|x)
[Mengersen et al., 2011] or
log[f(x|✓(t+1))]   log[f(x|✓(t))]
2.2.3 Confidence Intervals using EM Algorithm
When all the data is complete and does not contain any missing data, we can calculate
a 100(1  ↵)% confidence interval for ✓ by computing the Fisher Information matrix
[Shao, 2003] from the sample and
[✓ˆ   Z↵/2( 1p
I(✓)
), ✓ˆ + Z↵/2(
1p
I(✓)
)]
When there is missing information, the EM algorithm is commonly used to estimate
the parameters. To calculate the confidence intervals for MLEs of incomplete data out
of the EM algorithm we use the observed information matrix of the incomplete data
[Louis, 1982, Meilijson, 1989, Lange, 1995, Oakes, 1999]. Louis (1982) defines the
notation of the gradient and the negative of the second derivatives of the complete
likelihood,
S(Y, ✓) =
@ logL(✓|Y )
@✓
and B(Y, ✓) =  @
2 logL(✓|Y )
@✓2
and the gradient of the observed likelihood
S⇤(X, ✓) =
@ logL(✓|X)
@✓
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where S⇤(x, ✓) = EY |X,✓[S(Y, ✓)] and S⇤(x, ✓ˆ) = 0. Then, the observed information
matrix of the incomplete data can be obtained using
IX(✓) = EY |X,✓[B(Y, ✓)]  EY |X,✓[S(Y, ✓)ST (Y, ✓)] + S⇤(x, ✓)S⇤T (x, ✓)
or another way to think about it is
IX = I(✓ˆ) = IY (✓)  IY |X
Oakes (1999) shows the function Q(✓|✓(t)) can be used in the maximization of
the observed likelihood L(✓|x). Therefore, when calculating the observed information
matrix of the incomplete data, it is su cient to use
I(✓) =  @
2Q
@✓2
|✓=✓ˆ
To calculate a 100(1   ↵)% confidence interval for ✓, we then use the same formula
as above
[✓ˆ   Z↵/2( 1p
I(✓)
), ✓ˆ + Z↵/2(
1p
I(✓)
)]
2.3 Hidden Markov Models
Hidden Markov models are an extension of mixture models imposing a dependence
structure in the data. Several good introductions to HMMs exist [Rabiner, 1989,
Durbin et al., 1998]. In this section, the mathematical theory behind di↵erent prop-
erties of HMMs will be discussed.
2.3.1 Higher-order HMM
The first-order Markov chain can be extended to an n-th order Markov chain. Con-
sider the case when n = 2. A second-order Markov chain {Xn, n = 0, 1, 2, . . .} with
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distribution P and finite state space S = {s0, s1, . . . , sN} has the property
Pijk = P [Xn+1 = k|Xn = j,Xn 1 = i]
A second-order hidden Markov model is similar to the first-order except the di↵erence
is the way the transition probability matrix is defined. The unobservable chain given
by ⇡ is now characterized by the transition probabilities
Pijk = P [⇡n = k|⇡n 1 = j, ⇡n 2 = i]
Let the beginning of the process be defined by ai = P (⇡1 = i) or probability of
starting in state i. We do not observe the path of the chain ⇡n, but we do observe a
new set of states with given second-order emission probabilities
eij(b) = P [Xn = b|⇡n = j, ⇡n 1 = i]
defined as the probability that we observe state b given the unobservable chain is in
state j at the n step and state i at n  1. Then, the joint probability of the observed
sequence X and unobservable sequence ⇡ is given by
P (X, ⇡) = ax1P⇡1,⇡2
LY
n=2
e⇡n 1⇡n(xn)P⇡n,⇡n 1,⇡n 2
The same three questions asked above have also been answered with second-order
extensions of the following algorithms: Viterbi algorithm [Thede and Harper, 1999],
Forward algorithm and Baum-Welch [Watson and Chung Tsoi, 1992]. The Baum-
Welch algorithm (also called the forward-backward algorithm) is an EM algorithm
commonly used to estimate the parameters in a hidden Markov model. For details
related to the estimation steps see [Blimes, 1998].
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2.3.2 Stationary and Non-Stationary HMM
A non-stationary Markov model {Xn, n = 0, 1, 2, . . .} with distribution P is charac-
terized by the property that the transition probability matrix is a function of the
state duration distribution Pi(d) where d is the state duration or often referred to as
sojourn time. For stationary HMMs, if d is the duration of a particular state sk then
the duration distribution is given by
Pk(d) = P
d 1
kk (1  Pkk)
and is geometrically distributed [Djuric and Chun, 2002] for Markov chains. The du-
ration distribution is exponentially distributed in continuous-time Markov processes.
In some applications, this assumption of a geometric distribution is inappropriate.
Non-stationary HMMs overcome this limitation and allow the transition probabilities
to depend on the state duration
Pij(d) = P (⇡n = j|⇡n 1 = ⇡n 2 = . . . = ⇡n d = i)
The relationship between the duration distribution Pk(d) and transition probabilities
Pij(d) are given by
Pii(d) =
8><>: 1  Pi(d) if d = 11 Pdk=1 Pi(k)
1 Pd 1l=1 Pi(l) if d > 1
and for i 6= j
Pij(d) =
8><>: wijPi(d) if d = 1wij Pi(d)1 Pd 1l=1 Pi(l) if d > 1
with weights satisfying X
j
wij = 1 for i 6= j
An important relationship between HMMs and NSHMMs is that if d = 1 or
Pij(d) is constant where i 6= j then the NSHMM reduces to a stationary HMM
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[Bae et al., 2008]. The duration distribution Pi(d) may be defined by any distribution,
but it is often defined as a truncated Poisson distribution
Pi(d) / ✏
d
i e
 ✏i
d!
where ✏i is the parameter for the Poisson distribution associated with the ith state
and ✏ > 0 [Djuric and Chun, 2002, Bae et al., 2008].
2.3.3 Homogeneous and Inhomogeneous HMM
An inhomogeneous Markov model {Xn, n = 0, 1, 2, . . .} with distribution P is charac-
terized by the property that the probability of transitioning between states depends
not only on the previous and current state, but also at what position the process is
along a given sequence. For a homogeneous Markov model the transition probability
matrix is the same regardless of position.
2.3.4 Bayesian Methods for HMM
The parameters in hidden Markov models are most commonly estimated using it-
erative algorithms as mentioned in Section 1.1.3 such as the Viterbi, Forward, and
Baum-Welch algorithms. These iterative algorithms may not be the most e cient for
parameter estimation. Other techniques such as Markov Chain Monte Carlo (MCMC)
estimation can be used. A review of how to implement HMMs for the Bayesian mod-
eler has been performed [Scott, 2002]. Scott discusses how to obtain the posterior
distribution of the parameters, to estimate the HMM, and to use diagnostics to asses
model validity and MCMC convergence.
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2.4 Basic Principles in Genetic Mapping
2.4.1 Mendelian Inheritance
Gregor Mendel studied heritable traits in the 1860s and described two laws that ex-
plain how heritable traits are passed from parents to o↵spring. The first law called
Law of Segregation says a pair of genes for a given trait will segregate randomly into
gametes which are passed on to the o↵spring. The second law called Law of Inde-
pendent Assortment says that during gamete formation the segregation of one gene
pair is independent of other gene pairs [Balding et al., 2007]. Therefore, a Mendelian
trait or disorder is described as a trait that is influenced by a single gene and follows
a Mendelian inheritance pattern.
2.4.2 Recombination
The second law (Law of Independent Assortment) is true for many pairs of genes but
fails when considering genes that are linked. The statistic that describes the level of
genetic linkage between a pair of genes is ✓ = P (recombinate gamete):
✓ =
8>>>><>>>>:
1/2 when genes are unlinked
0 when genes are completely linked
(0, 1/2) genes are said to be ”linked” or ”in genetic linkage”
where recombination is described as the chromosomal exchange of DNA. Recombi-
nation frequencies are not distributed evenly across chromosomes because there are
clear hotspots of recombination.
Genetic distances between genes can be estimated using recombination fractions
and genetic map functions. The Haldane map function [Haldane, 1919] is described
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using the recombination frequency ✓ and map distance d in centiMorgans (cM)
✓ =
1
2
(1  e 2d)
or the inverse estimates the genetic distance in terms of recombination frequency
d =  1
2
log(1  2✓)
Other genetic map functions have been proposed [Kosambi, 1944, Carter and Falconer, 1951,
Sturt, 1976, Rao et al., 1977, Felsenstein, 1979, Karlin and Liberman, 1978]
2.5 Genetic Architecture of Diseases
Genetic diseases have been characterized in the following two ways: 1) Mendelian
diseases and 2) common diseases. We have previously discussed Mendelian genetics
in Section 2.4.1. Mendelian diseases are influenced by a single causative mutation
(low frequency) or single gene and follow the Mendelian inheritance pattern.
The second type of disease, common diseases, are considered to be complex dis-
eases in the sense that multiple mutations of higher population frequency or multiple
genes and possibly their interaction with each other and the environment all have an
e↵ect on the disease outcome. There is a debate about the genetic basis of complex
diseases such as cancer and diabetes. Two proposed etiologies for complex traits are:
1. Common Disease, Common Variant (CDCV) hypothesis: common variants with
low to modest e↵ect sizes that influence the disease in a significant portion of the
population [Reich and Lander, 2001, International HapMap Consortium, 2003,
Risch and Merikangas, 1996], or the
2. Common Disease, Rare Variant (CDRV) hypothesis: rare variants with large
e↵ect sizes that individually only account for a small proportion of disease in
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the population [Pritchard, 2001, Bodmer and Bonilla, 2008, Schork et al., 2009,
Manolio et al., 2009]
Evidence for both hypotheses has been given [Schork et al., 2009]. Figure 2.1 depicts
a graph showing the feasibility of identifying variants by risk allele frequency and
strength of genetic e↵ect (odds ratio). This figure was taken from Manolio et al.
(2009). Figure 2.2 represents the genetic architecture of disease and what current
methods are applied to finding these risk and causative alleles. This figure was taken
from Singleton et al. (2010).
Figure 2.1 : Feasibility of identifying variants by allele frequency and strength of
genetic e↵ect [Manolio et al., 2009]
Genetic studies typically use a particular method to target a particular range of
allele frequencies and e↵ect size believed to be associated or linked to the trait of
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Figure 2.2 : The landscape of genetic architecture of disease and the current methods
to finding the risk and causative variants [Singleton et al., 2010]
interest. Genome-wide association studies (GWAS) have focused on common alle-
les with modest e↵ect sizes while linkage studies which require large pedigrees have
focused on rare alleles with large e↵ect sizes such as Mendelian traits. In the ad-
vent of next-generation sequencing, exome sequencing can allow low-frequency or
rare, moderate-risk alleles to be found. Current methods available to identify these
rare variants are whole genome and whole exome sequencing technologies. The first
proof-of-concept example was by Ng et al. (2009) who showed that next-generation
sequencing can be used to identify disease-causing mutations in only twelve unre-
lated individuals (four cases and eight controls) with a rare dominantly inherited dis-
order, Freeman-Sheldon syndrome, with a previously known cause [Ng et al., 2009,
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Cirulli and Goldstein, 2010]. Another important example is Ng et al. 2010 which was
the first paper to identify the gene for a rare Mendelian disorder (Miller syndrome)
with an unknown cause using exome sequencing in only four cases and eight controls
[Ng et al., 2010]. These successes in identifying causes of Mendelian diseases indicate
that whole genome sequencing of an even smaller number of individuals can identify
causal variants.
2.6 Missense Mutations and Mixture Models
Nonsynonymous changes found as single nucleotide polymorphisms (SNPs) resulting
in amino acid substitutions in the encoded protein product are called missense muta-
tions and may or may not a↵ect protein function. Predicting the impact of missense
mutations on protein function is an important factor in identifying and determining
the clinical importance of disease-causing mutations. Many computational or in silico
methods including SIFT [Ng and Heniko↵, 2001], Align-GVGD [Mathe et al., 2006,
Tavtigian et al., 2008b], PolyPhen-2 [Ramensky et al., 2002, Adzhubei et al., 2010],
and Xvar [Reva et al., 2007, Reva et al., 2011] have been developed, but they of-
ten lead to conflicting results leaving the user without guidance in assessing the
pathogenic impact of missense mutations on protein function as discussed in Chapter
3 of this thesis.
In Chapter 4, we develop two statistical models based on the capture-recapture
paradigm which combine the discordant functional predictions in a statistically rigor-
ous manner and estimate a unified posterior probability of functionality or pathogenic-
ity for each missense mutation. Unlike previous methods, our probabilistic approach
requires no training set or calibration and estimates the accuracy (sensitivity and
specificity) of each individual in silico method in the absence of a gold standard by
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taking advantage of the fact these methods disagree. We define a mixture model with
the weight parameter representing the overall proportion of deleterious mutations and
perform parameter estimation using the Expectation-Maximization algorithm. Our
approach is able to account for the accuracy of each in silico method when combining
the functional predictions.
2.7 Identity-by-Descent and Hidden Markov Models
Several disease-gene identification projects have recently used whole-exome sequenc-
ing as a technique to identify disease-causing variants in unrelated individuals a↵ected
by the same Mendelian disorder [Choi et al., 2009, Ng et al., 2009, Ng et al., 2010].
These projects used an “intersection” approach [Robinson et al., 2011] by searching
for the same rare variants found in all of the a↵ected individuals while filtering or
eliminating common variants found in large databases such as dbSNP, HapMap and
1000 Genomes Project. Though this is an e↵ective technique in identifying genes
associated with Mendelian disorders in unrelated individuals, it not ideal for re-
lated individuals because it does not take into account additional information from
families. Instead, researchers have combined linkage analysis with whole-exome se-
quencing as a way to identify disease genes in related individuals; however, this
technique is not optimized for the high error rates in whole-exome sequencing data
[Ro¨delsperger et al., 2011]. Therefore, researchers studying Mendelian disorders are
utilizing the theory of identity-by-descent as a tool to filter error-prone exome se-
quencing data and identify disease-causing mutations in areas of the genome that
were transmitted through Mendelian inheritance only, in particular for autosomal
recessive diseases.
In autosomal recessive disorders, all a↵ected children share two haplotypes that
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are identical-by-descent (IBD). Therefore the disease gene must be located in this
IBD region [Ro¨delsperger et al., 2011]. In consanguineous families, chromosomal seg-
ments inherited IBD are genetic regions in two or more individuals that are inherited
from a common ancestor while regions inherited identical-by-state (IBS) have iden-
tical DNA sequence but were not necessarily inherited from a common ancestor. In
non-consanguineous families, the chromosomal segments can be defined IBD if each
a↵ected sibling inherits the same haplotype from each parent. In whole-exome se-
quencing, the observed genotypes of a↵ected children are IBS or not for each ith
marker. The goal is to predict the number of unobserved shared alleles IBD = 0,
1, 2 between a↵ected siblings. Hidden Markov models are one way to make such
predictions. These models are used to identify regions of IBD and are interested in
predicting whether a given marker is IBD given the IBS status. Therefore, using the
notation defined in Section 1.1.3, the IBD status is the unobservable markov chain
⇡n and the observable IBS status is given by Xn.
In Chapter 6 of this thesis, we consider several inhomogeneous hidden Markov
models to identify IBD regions. These models are an extension from the first-order
hidden Markov model developed by Rodelsperger et al. (2011) which was based on
inhomogeneous transition probabilities. We also redefine the emission probabilities to
conditional emission probabilities and develop a Viterbi-type algorithm for parameter
estimation. These methods will provide researchers a tool to filter large portions of
the exome in search of finding causal variants for a given disease.
Because the idea of employing HMMs to identify regions of IBD has been widely
studied, a brief review of the methods for related individuals will be given.
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2.7.1 Methods for related individuals
Leutenegger et al. (2003) used a first-order HMM to estimate the inbreeding coe -
cient while accounting for marker dependencies to ultimately make inference on the
IBD status at each marker for a given inbred individual. Using a maximum-likelihood
approach, their method defined transition probabilities that depend on the distance
dn between the n and n + 1 markers in centimorgans (cM),   the inbreeding coe -
cient and ⌘ the number of meiotic steps to the most recent common ancestor. The
emission probabilities, which connect the observed genotypes with the unobserved hid-
den states, were defined in terms of population frequencies [Leutenegger et al., 2003].
Wang et al. (2006) expanded on this model by accounting for linkage disequilibrium
(LD). Because they used marker data with a higher density, they could no longer
assume markers to be in linkage equilibrium like Leutenegger et al. (2003). Instead,
they assumed the nearby markers to be in linkage disequilibrium and argued applying
the original model without accounting for LD would result in an over-prediction of
regions of IBD. The main modification to the original method was to redefine emis-
sion probabilities as the probability of a genotype Xn being dependent not just on
the IBD status ⇡n, but also the previous genotype Xn 1 (or P (Xn|Xn 1, ⇡n, ⇡n 1)).
This second-order emission probability uses haplotype frequencies at two neighbor-
ing markers and also incorporates the probability of a genotyping error as well as
missing data [Wang et al., 2006]. Though the emission probabilities were defined as
second-order, the Markov chain still remained a first-order allowing the regular Viterbi
algorithm to be used.
Albrechtsen et al. (2009) also employed a first-order HMM to estimate the prob-
ability of being IBD between pairs of related or distantly related individuals for each
marker, but they redefined the hidden states at each marker to be defined as the
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number of alleles shared IBD between pairs of individuals (i.e. 0, 1, 2) instead of the
binary status of IBD or not IBD as before. Since they used a higher density marker
data set, their model also accounted for linkage disequilibrium using haplotype fre-
quencies, but the main di↵erence between this method and the method of Wang et al.
(2006) is that the marker genotypes in the emission probabilities were allowed to be
conditioned on any of the previous markers, not just the adjacent one while assuming
the same hidden state for the two markers (or P (Gj,ki |Gj,kh , ⇡i = ⇡h)). Han and Abney
(2011) also developed a set of conditional emission probabilities which depended not
only on allele frequency, but also haplotype frequency estimated using the observed
and true genotypes. This method was developed for dense genotype data and the
purpose was to incorporate LD in IBD estimations [Han and Abney, 2011].
A novel HMM approach was developed by Li et al. (2010) who introduced the
concept of an inheritance-generating function between a pair of alleles in a specified
pedigree structure. The hidden states represent the number of shared IBD alleles
between each pair of individuals. This model is extended from Lander and Green
(1987) in the sense that the marginal probability of being IBD at a particular marker
depends not only on the observed IBS status, but also the relationship between the
pair of individuals of interest. Because the derived transition probabilities must ac-
count for any type of relationship between the individuals, the inheritance-generating
function was developed.
The most recent first-order HMM method is from Rodelsperger et al. (2011) who
were the first to use whole-exome sequencing data while the three methods above
all used a sequencing technology called SNP A↵ymetrix array. This is a platform
to directly test for known polymorphisms across the genome of sizes ranging from
100K-2000K depending on the chip. This method defines the IBD status as a binary
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indicator if the n a↵ected siblings from a consanguineous or non-consanguineous fam-
ilies all share the observed genotype at a marker or not. The transition probabilities
are inhomogeneous because they depend on position-specific recombination rates and
the marginal probabilities, describing the probability of the hidden IBD state given
the observed IBS state, are homogeneous. This method is specific for autosomal re-
cessive Mendelian inheritance patterns. Another major di↵erence is that the above
methods incorporate observed genotypes into their transition probability matrices
and emission probabilities, while this method only asks if the genotypes are equal or
not. Thus, the emission probabilities are defined in terms of the probability of a false
genotype call at a single variant position ✏. Chapter 6 expands on the Rodelsperger
et al. (2011) method by extending the model to inhomogeneous second-order HMMs
and considers conditional emission probabilities which vary as a function of minor
allele frequency.
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Chapter 3
Interpreting the Functionality of Misense
Mutations
A major bottleneck in genomics and bioinformatics is the interpretation of missense
mutations. In the protein-coding regions of the genome, predicting the impact of
missense mutations on protein function is a di cult task because missense mutations
do not necessarily impact protein function. Many computational or in silico algo-
rithms have been developed to predict the functionality or pathogenicity of muta-
tions observed in human exomes, but they often lead to conflicting results leaving the
researcher without guidance in how to prioritize the mutations identified for further
evaluation in biological assays. These in silico methods base their predictions on the
idea of using evolutionary conservation as a measure of pathogenicity by employing
protein sequence alignments as the standard input to these in silico methods.
In this chapter, we perform a study investigating how functional predictions vary
between using di↵erent in silico methods, and also vary using di↵erent protein se-
quence alignments. This study highlights the di culty in predicting missense muta-
tion functionality and shows the in silico methods have a high degree of disagreement.
We note that Section 3.1 essentially contains the same information as the paper we
published in Human Mutation [Hicks et al., 2011] which was recently highlighted and
discussed in Nature [Baker, 2012]. Then, in Section 3.2 we review possible reasons
for the disagreement between predictions of functionality and provide an example of
the degree of disagreement. In Section 3.3 we discuss additional technical problems
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related to using these in silico methods. Also, we give an example of the importance
of properly assessing the accuracy of these methods which we published in Human
Mutation [Hicks et al., 2013].
3.1 in silico Methods: Predictions of Functionality
A number of algorithms have been developed to predict the impact of missense mu-
tations on protein structure and function including sequence and structure-based ap-
proaches. A review of available computational methods for assessing the functional ef-
fects of missense mutations has been performed [Ng and Heniko↵, 2006, Karchin, 2009,
Thusberg and Vihinen, 2009, Jordan et al., 2010]. Many methods base their predic-
tions on phylogenetic information implying the pathogenicity of missense mutations
is assessed from the observed amino acid variation at a given residue in the multiple
sequence alignment employed. Variables that a↵ect the prediction accuracy of these
algorithms include the gene examined, the number of sequences in the alignment,
the evolutionary distances among species, the algorithm used, and the importance
of absolute amino acid conservation versus relatively conservative missense changes
[Greenblatt et al., 2003]. Researchers have used multiple methods as a way to increase
confidence in identifying deleterious mutations when predictive results di↵er between
methods [Chan et al., 2007, Chun and Fay, 2009] but it has been argued these algo-
rithms have major similarities underneath the lid and the correlation of their outputs
is the result of similarity of their inputs, which is not a cause for increased confidence
[Karchin, 2009]. Problems in comparing multiple methods extend further because
there is no standard classification system used to categorize the predicted function-
ality of the variants, needed to provide a statistical measure of performance of the
methods. Researchers have addressed this problem by grouping the predictions from
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the algorithms into two main categories: variants that are predicted to be deleterious
or neutral [Chan et al., 2007].
Several studies have compared the prediction accuracy of sequence
[Balasubramanian et al., 2005, Mathe et al., 2006] and structure-based algorithms
[Bao and Cui, 2005, Chan et al., 2007, Chao et al., 2008] using alignments generated
by the algorithms or manually curated alignments. However, it remains unclear how
the predictions change when the sequence alignment provided changes, since it has
been suggested that when the outputs from the algorithms di↵er, it is most likely due
to employing di↵erent protein sequence alignments [Karchin, 2009]. Past research has
shown high predictive values for methods that use evolutionary sequence conservation,
surprisingly with or without protein structural information [Chan et al., 2007]. Since
sequence alignments influence sequence-based methods which ultimately generate
measures of pathogenicity [Kryukov et al., 2007], it is important to determine which
types of sequence alignments will lead to better in silico assessments [Tavtigian et al., 2008a].
In this study we employed four commonly used in silico algorithms:
1. SIFT (http://sift.jcvi.org/). The method Sorts Intolerant From Tolerant is a
sequence homology-based tool that predicts variants in the query sequence as
neutral or deleterious using normalized probabilities calculated from the input
multiple sequence alignment [Ng and Heniko↵, 2001]. SIFT obtains this multi-
ple sequence alignment by internally generating it or by allowing the user to sub-
mit their own FASTA-formatted alignment. The alignment built by SIFT con-
tains homologous sequences with a medium conservation measure of 3.0 where
conservation is represented by information content [Schneider et al., 1986] to
minimize false positive and false negative error. The authors mention better
results may be obtained using only ortholog sequences because including par-
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alogs can confound predictions at residues conserved only among the orthologs
[Ng and Heniko↵, 2002]. Variants at a position with normalized probabilities
less than 0.05 are predicted deleterious and predicted neutral with a probability
greater than or equal to 0.05.
2. Align-GVGD (http://agvgd.iarc.fr/). This method predicts variants in the
query sequence based on a combination of Grantham Variation (GV), which
measures the amount of observed biochemical evolutionary variation at a partic-
ular position in the alignment, and Grantham Deviation (GD), which measures
the biochemical di↵erence between the reference and amino acid encoded by
the variant [Mathe et al., 2006]. The original classifier uses a set of five criteria
based on GV and GD which classifies variants as neutral, unclassified’ or dele-
terious [Mathe et al., 2006]. For example, in the extreme case of GV = 0, the
alignment is completely conserved at that position and any other variant will
be considered deleterious. The new classifier provides ordered grades ranging
from the most pathogenic to least likely pathogenic [Tavtigian et al., 2008a].
The algorithm has primarily been used for a few clinically relevant tumor sup-
pressor genes such as BRCA1, TP53 and the author provides highly manually
curated alignments which may cause a favorable bias towards this algorithm
when applied to the class of genes studied here. These alignments contain a
small number of full-length ortholog sequences with a long range of evolution-
ary depth. The author argues the alignment should not only be restricted to true
orthologs due to the biological phenomenon of functional diversification among
paralogs [Abkevich et al., 2003], but also should sample enough sequences at
su cient evolutionary distance from each other (alignment depth) for the best
accuracy of the algorithms [Tavtigian et al., 2008a]. The experimentalist can
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provide his or her own alignment for other genes.
3. PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/). This method is the
latest tool developed by the authors of the original PolyPhen [Ramensky et al., 2002].
Its novel features include the set of predictive features, the alignment pipeline
and the probabilistic classifier based on machine-learning methods. PolyPhen-
2 predicts variants as benign, possibly damaging or probably damaging based
on eight sequenced-based and three structure-based predictive features which
were selected by an iterative greedy algorithm. Another useful feature is the
algorithm calculates a Bayes posterior probability that a given mutation is dele-
terious [Adzhubei et al., 2010]. The web-based version requires use of the built
in alignment pipeline, but the user may download and install the latest ver-
sion of PolyPhen-2 to submit their own alignment. The alignment pipeline
used in PolyPhen-2 selects homologous sequences using a clustering algorithm
and then constructs and refines the alignment yielding an alignment containing
both orthologs and paralogs that may or may not be full length, which yields
a wider breadth of sequences but decreased depth compared with the Align-
GVGD alignment. The authors argue this leads to more accurate predictions
because a majority of deleterious variants a↵ect protein structure compared to
specific protein function [Adzhubei et al., 2010].
4. Xvar (http://xvar.org/). This recently developed web-based algorithm
[Reva et al., 2011] by the same authors of the original algorithm combinatorial
entropy optimization [Reva et al., 2007] cannot accept user-defined multiple se-
quence alignments from the investigator as input. The Xvar server can map the
variant to both the Uniprot (http://www.uniprot.org/) and NCBI Reference Se-
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quence (Refseq) protein (http://www.ncbi.nlm.nih.gov/refseq/) and to the 3D
structure in Protein Data Bank (PDB) (http://www.pdb.org/pdb/) if avail-
able. Once the Uniprot IDs are identified, they are used to build local sequence
alignments and extract information about the domain boundaries, annotated
functional regions and protein-protein interaction instead of using full-length
sequences as in the other three algorithms. Xvar predicts variants as neutral,
low, medium or high.
3.1.1 Protein Sequence Alignments
The four multiple protein sequence alignments used as input to compare the variability
of predictions from each algorithm include:
1. An automatically generated alignment from SIFT
2. An automatically generated alignment from PolyPhen-2 with a wide breadth of
sequences (http://genetics.bwh.harvard.edu/pph2/). After downloading and in-
stalling the latest version of PolyPhen-2, the alignment automatically generated
by the alignment pipeline can be obtained in a FASTA-formatted alignment.
3. A small highly curated alignment with long evolutionary depth ideal for Align-
GVGD (http://agvgd.iarc.fr/). The BRCA1, MSH2, MLH1 and TP53 curated
protein alignments can be directly obtained from the website and formatted
into a FASTA-formatted alignment.
4. An uncurated alignment (http://www.uniprot.org/) automatically generated in
Uniprot using the built in ClustalW feature with sequences included based on
a criteria of 50% identity. This alignment was used as an unbiased alignment
in the sense that none of the programs were built or trained on this type of
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alignment, which makes it suitable for testing the variability of the predictions
from these algorithms.
Specific details related to the settings for each in silico method are given here:
1. SIFT. The web-based method SIFT version 4.0.3 was used with all default
settings. The alignment built by SIFT was created using the SIFT Sequence
option. The other three multiple sequence alignments were each submitted
under the SIFT Aligned Sequences option. Variants were predicted as neutral
or deleterious.
2. Align-GVGD. The web-based method Align-GVGD was used with all default
settings. The Align-GVGD alignment for BRCA1, MSH2, MLH1 and TP53
are freely available on the website. Each of the other three types of multiple
sequence alignments were also submitted. Variants were predicted as neutral,
unclassified or deleterious. For this study, the variants predicted as neutral and
unclassified were grouped together as neutral variants.
3. PolyPhen-2. The latest version of PolyPhen-2 version 2.0.22 and helper pro-
grams were downloaded and installed on 3.06 GHz Intel Core 2 Duo processor
with 6GB L2 Cache memory computer at Rice University. The standard output
reported by the downloaded algorithm uses the default classifier model HumDiv,
but predictions may also be obtained using the HumVar model reporting only
minor di↵erences between the two models (data not shown). The alignment
built by PolyPhen-2 was automatically generated. The other three multiple se-
quence alignments could be submitted because the downloaded algorithm allows
the user to submit their own FASTA-formatted alignment. Variants were pre-
dicted as benign, possibly damaging or probably damaging. For this study, the
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variants predicted as possibly damaging and probably damaging were grouped
together as deleterious variants.
4. Xvar. The web-based method Xvar version 0.75 beta was used with all default
settings. The variants were submitted along with their Uniprot accession IDs.
They were predicted as neutral, low, medium and high. For this study, the vari-
ants predicted as neutral and low were grouped together as neutral variants and
the variants predicted as medium and high were grouped together as deleterious
variants.
All field tests using the four algorithms were run during July 23-27, 2010 on a Mac
OS X 10.5.8. Safari 5.0 was used to access the web-based methods.
3.1.2 Locus-Specific Databases
Sets of missense mutations with known functionality are needed to compare the algo-
rithms. Locus-specific databases (LSDBs), which are curated collections of sequence
variants in genes associated with disease [Greenblatt et al., 2008], can be used as a
gold standard containing both neutral and deleterious variants. The variants from
the LSDBs are evaluated by the algorithms which allow a comparison of the al-
gorithms for sensitivity, specificity and receiver operating curves. Tavtigian et al.
(2008) argue the best data sets for comparing these algorithms are LSDBs which
are curated by individuals or groups specialized in the analysis of each specific gene
[Chan et al., 2007, Chao et al., 2008]. A description of LSDBs for cancer suscep-
tibility genes available on the internet can be found in Greenblatt et al. (2008).
We evaluated the algorithms on four sets of variants with known functionality from
BRCA1 (OMIM: 113705), MSH2 (OMIM: 609309), MLH1 (OMIM: 120436) and TP53
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(OMIM: 191170) cancer associated genes.
1. The online Breast Cancer Information Core (BIC) [Szabo et al., 2000] mutation
database (http://research.nhgri.nih.gov/bic/) was used to identify neutral (n =
16) and deleterious (n = 17) mutations from BRCA1. The steering committee
of the BIC has manually reviewed available data from the literature and likeli-
hood ratios [Goldgar et al., 2004] to define clinically relevant or benign missense
changes using three categorizations of clinically relevant (yes, no or unknown).
2. The MLH1 missense mutations were obtained from two papers [Chan et al., 2007,
Chao et al., 2008]. The first paper performed mismatch repair functional assays
to identify neutral (n = 10) mutations with wild-type activity and deleterious
(n = 18) mutations with impaired mismatch repair activity. These MLH1 mu-
tations were compared in a previous paper [Chan et al., 2007] that used the
three algorithms SIFT, Align-GVGD and PolyPhen, but they did not compare
the results using di↵erent alignments. The second paper compiled a list of all
known MLH1 missense mutations from several LSDBs with supporting data
which was used as rigorous criteria to classify the variants as neutral (n = 18)
or deleterious (n = 37). Subtracting the overlap between the papers yielded a
total of (n = 21) neutral and (n = 39) deleterious variants.
3. The MSH2 variants were obtained from the same two papers as the MLH1
variants above [Chan et al., 2007, Chao et al., 2008]. The first paper identified
neutral (n = 3) mutations with wild-type activity and deleterious (n = 11)
mutations with impaired mismatch repair activity. These MSH2 mutations were
also compared in the paper. The second paper compiled classified neutral (n =
8) or deleterious (n = 13) variants with the same criteria as above. Subtracting
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the overlap between the papers yielded a total of (n = 11) neutral and (n = 19)
deleterious variants.
4. The online TP53 database from the International Agency for Research on Can-
cer (IARC) was used to identify neutral (n = 4) and deleterious (n = 140)
mutations from the TP53 gene (http://www-p53.iarc.fr/). A description of in-
clusion criteria for the polymorphisms and germline deleterious variants is given
[Olivier et al., 2002].
3.1.3 Comparing the Accuracy of in silico Methods
In this analysis we compare the predicted functionality of the same set of curated
missense mutations in cancer-associated genes using existing algorithms SIFT, Align-
GVGD, PolyPhen-2 and Xvar. In addition, we provided SIFT, Align-GVGD and
Polyphen-2 the same four sequence alignments for each gene analyzed to determine
the impact of the alignment on prediction. Xvar is excluded from this latter analysis
because it currently does not accept multiple sequence alignments as input.
Several statistical measures of performance were used to compare the performance
of the algorithms for each of the four sets of mutations with known functionality. Us-
ing the notation of true positives (TP), true negatives (TN) false positives (FP)
and false negatives (FN), we compute sensitivity as TP / (TP + FN) (probabil-
ity of identifying true deleterious mutations) and specificity as TN / (TN + FP)
(probability of identifying true neutral mutations). Some algorithms provide more
than two prediction categories, e.g. neutral, possibly and probably damaging for
Polyphen-2. Therefore, as described above for each method, we grouped the output
into two categories deleterious and neutral based on similar groupings in previous
studies [Chan et al., 2007].
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A receiver operating characteristic (ROC) curve [Fawcett, 2006] is a technique that
allows combining the mutation data and visualizing the performance of the algorithm
with the native alignment and the three additional alignments provided (treated as a
probabilistic classifier in this case). The ROC graph is a two dimensional graph that
plots sensitivity against 1 - specificity depicting the relative tradeo↵s between the
true positives and false positives. ROC curves can be based on discrete or continuous
classifiers. An algorithm that only reports a finite set of prediction categories, such
as neutral or deleterious is a discrete classifier. However, if the algorithm reports a
continuous score, being the degree or probability of a mutation belonging to a predic-
tion category then it is a continuous classifier. We have reported the ROC curves in
Figure 3.3 using the associated continuous scores available for any mutation tested in
each algorithm (in fact, these scores underlie the discrete classifications). Accuracy
is measured by the area under the ROC curve (AUC); an area of 1 corresponds to a
perfect prediction, whereas an area of 0.5 corresponds to a pure chance prediction.
AUC less than 0.5 may be interpreted as a systematically incorrect prediction. The
AUC of a given classifier can be represented as the probability that given an align-
ment the algorithm will rank a randomly chosen deleterious mutation higher than a
randomly chosen neutral mutation [Fawcett, 2006]. In our case, we use an AUC for-
mula equivalent to the Wilcoxon test of ranks [Hanczar et al., 2010]. The confidence
intervals of the estimated AUC values are identical with the confidence intervals of
the Wilcoxon rank statistic [Hogg and Tanis, 2006]. The ROC curves and AUC val-
ues for all algorithm/alignment pairs were computed using the ROCR package in R
[Sing et al., 2005].
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BRCA1 Tumor Suppressor Gene
The native BRCA1 sequence alignments were built for the four algorithms as de-
scribed in Methods. In addition, the three non-native alignments were used as inputs
in each of the three algorithms, SIFT, Align-GVGD and PolyPhen-2 (see Table 3.1
for the number of sequences in each alignment). A description of the set of the well-
characterized neutral (n = 16) and deleterious (n = 17) BRCA1 variants from the
BRCA1 LSDB is described in Methods.
Figure 3.1A shows the output of each algorithm using the neutral (n = 16) BRCA1
variants when given the same four alignments. We found the algorithm PolyPhen-
2 to be the least sensitive to the varying alignments. The Align-GVGD algorithm
was the most sensitive to the varying alignments because the algorithm will predict
all variants neutral, regardless of pathogenicity, when provided an alignment with
a large number of sequences such as the PolyPhen-2 and Uniprot 50% alignments.
Although this translates to an apparently high specificity for the Align-GVGD al-
gorithm, this feature of the algorithm leads to the prediction of neutrality being
solely based on the number of sequences in the alignment. Surprisingly, we see that
algorithms do not necessarily perform best using their own alignment (Table 3.1).
For example, the SIFT algorithm has the highest specificity using the Align-GVGD
alignment (compared to its own) possibly because the Align-GVGD alignment is only
made up of orthologs [Ng and Heniko↵, 2002]. We also found that the SIFT algo-
rithm overcalls neutral variants as deleterious, low specificity, as previously noted by
others [Mathe et al., 2006, Karchin et al., 2008]. Using its own or native alignment,
the Xvar algorithm has specificity (Table 3.2) that is equal to or smaller than the
specificities of the other three algorithms using their optimal alignment (Table 3.1).
The results in Figure 3.1B show the output of each algorithm for the deleterious
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Table 3.2 : Specificity and Sensitivity Summary Using the Xvar Default Alignment
for the Four Genes BRCA1, MSH2, MLH1, and TP53
Genes Specificity (%) Sensitivity (%)
BRCA1 56.3 82.4
MSH2 27.3 100
MLH1 33.3 100
TP53 50.0 95.7
(n = 17) BRCA1 variants when given the same four alignments. The Align-GVGD
algorithm shows a poor sensitivity, again because it incorrectly predicts all 17 delete-
rious variants as neutral when provided large number of sequences, as it is the case for
PolyPhen-2 and Uniprot 50% alignments. The algorithm PolyPhen-2 has the highest
sensitivity using the SIFT alignment which is another example of an algorithm per-
forming best with an alignment other than its own (Table 3.1). When comparing the
Xvar algorithm using its native alignment to the other algorithms, we see Xvar has a
high sensitivity (Table 3.2) that is similar to the sensitivities reported from the other
algorithms using their optimal alignment (Table 3.1).
MSH2, MLH1 Mismatch Repair Genes and TP53 Tumor Suppressor Gene
The native MSH2, MLH1 and TP53 sequence alignments were built for the four
algorithms as described in Methods. In addition, the three non-native alignments for
each gene were used as inputs in each of the three algorithms, SIFT, Align-GVGD
and PolyPhen-2 (see Table 3.1 for the number of sequences in each alignment). The
three sets of variants from MSH2 (n = 11 neutral, n = 19 deleterious), MLH1 (n
= 21 neutral, n = 39 deleterious) and TP53 (n = 4 neutral, n = 140 deleterious)
are described in Methods. Overall we found similar results to BRCA1 for variants
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from these three cancer genes (Table 3.1). However, SIFT algorithm reports higher
sensitivities using the MSH2 and MLH1 variants compared to the BRCA1 variants.
We also note that although for BRCA1 the highest specificity of the SIFT algorithm
was seen by using the Align-GVGD alignment this was not true for the other three
genes. The results for MSH2, MLH1 and TP53 using the Xvar algorithm are given in
Table 3.2 which again demonstrates the algorithm using its native alignment reports
similar specificity values to the other algorithms. When comparing sensitivity, Xvar
using its native alignment reports higher sensitivities (Table 3.2) that is equal to or
greater than the sensitivities of the other algorithms using their best alignment (Table
3.1) for all three genes.
Overall Sensitivity and Specificity
A boxplot summary of the sensitivity and specificity values for the three algorithms,
which combines the gene- and alignment-specific information, illustrates how much
variation is caused by employing di↵erent alignments (Figure 3.2).
For each alignment, the four sensitivity values are computed by grouping the muta-
tions within each of the four genes BRCA1, MSH2, MLH1 and TP53, yielding a total
of 16 sensitivity values for each algorithm. We note that there are only four neutral
TP53 variants which may inflate the specificity values; therefore we excluded TP53
specificity values in the figure and used only 12 specificity values for each algorithm.
We also computed confidence intervals for the sensitivity and specificity estimates,
using the Wilson score method [Agresti, 2002]. The results from Figure 3.2 show
PolyPhen-2 and SIFT both have a high median sensitivity of 0.90 and 0.85, respec-
tively. We note PolyPhen-2 and SIFT both have similar median specificity values,
0.40 and 0.52, respectively, highlighting that the specificities are significantly lower
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Figure 3.2 : Boxplots of specificity (spec) and sensitivity (sens) for each algorithm
as given in Table 1. Sensitivity values are reported using all four genes BRCA1,
MSH2, MLH1, and TP53, but TP53 is excluded in specificity values to account for
potential bias given that there are only four neutral variants. The three algorithms
are represented by SIFT (SIFT), Align-GVGD (A-GVGD), and PolyPhen-2 (PPH2).
than the sensitivities. Thus, these algorithms are more likely to make mistakes by
calling neutral variants deleterious. For both sensitivity and specificity PolyPhen-2
has a smaller interquartile range (IQR) than SIFT, which means that PolyPhen-2
is less sensitive to the sequence alignment employed. As noted previously, Align-
GVGD is very sensitive to the algorithm employed. The high specificity seen in
Align-GVGD is misleading because the algorithm predicts all variants neutral, re-
gardless of pathogenicity, when using alignments with a large number of sequences.
This feature of the algorithm also results in low sensitivity with large IQR. Thus,
even though Align-GVGD performs well using its own alignment, it is more depen-
dent on the alignment employed than either SIFT or PolyPhen-2. The results of this
analysis are that only PolyPhen-2 and SIFT are appropriate for use with non-native
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alignments that are not manually curated, with PolyPhen-2 modestly outperforming
SIFT. The corresponding boxplot for the Xvar algorithm is not provided because
Xvar requires the use of its native alignment; however, the median sensitivity is 0.98
and the median specificity (excluding TP53) is 0.33.
Receiver Operating Characteristic curves
Each algorithm provides a quantitative probability or score as output as well as a
prediction category, e.g. probably damaging for Polyphen-2. This enabled us to com-
pare alignment-specific information for each algorithm using the concept of receiver
operating characteristic (ROC) curves to provide a succinct graphical summary of
all four algorithms, treated as continuous classifiers (Figure 3.3A and Figure 3.3B;
also, see Statistics Section in Materials and Methods). Align-GVGD and PolyPhen-2
algorithms performed best using their native alignment, but the SIFT algorithm had
a higher AUC when using an alignment, manually curated Align-GVGD, other than
its own. When employing the optimal alignment for each algorithm, the AUC values
are 79% for all four algorithms. The PolyPhen-2 algorithm is shown to be the least
dependent on the alignment employed as seen by the nearly overlapping ROC curves
and similar AUC values for all four alignments provided. In comparison the SIFT and
Align-GVGD algorithms show much greater variation in their ROC curves employing
di↵erent alignments. As seen in Figure 3.2, Figure 3.3 shows PolyPhen-2 and SIFT
are the only two methods appropriate for use with non-native algorithm-generated
alignments. The area under the ROC curve (AUC) values are reported in Table 3.3
with the associated confidence intervals. When we rank the averaged AUC values for
each alignment strategy we obtain 0.790, 0.766, 0.674, and 0.579 for the Align-GVGD,
SIFT, PolyPhen-2 and Uniprot alignments, respectively.
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Table 3.3 : Area Under the Curve (AUC) from Receiver Operating Curves for Each
Algorithm Using Each Alignment Using Probabilities and Scores Associated with
Each Mutation Prediction
Algorithms Alignments AUC CIs
SIFT
SIFT 0.777 (0.690, 0.865)
Align-GVGD 0.790 (0.702, 0.877)
PolyPhen-2 0.730 (0.643, 0.818)
Uniprot 50% 0.487 (0.400, 0.575)
Align-GVGD
SIFT 0.747 (0.659, 0.835)
Align-GVGD 0.791 (0.703, 0.878)
PolyPhen-2 0.500 (0.412, 0.588)
Uniprot 50% 0.500 (0.412, 0.588)
PolyPhen-2
SIFT 0.773 (0.686, 0.861)
Align-GVGD 0.779 (0.692, 0.867)
PolyPhen-2 0.792 (0.704, 0.879)
Uniprot 50% 0.750 (0.662, 0.838)
Xvar Xvar 0.790 (0.703, 0.878)
Given that most investigators will utilize online tools where the algorithm employs
its native alignment we compared the ROC curves for the four algorithms using their
native alignments (Figure 3.3C). This analysis demonstrates no significant di↵erences
in the shape of the curve or AUC values (between 78-79%) for all four algorithms.
The same analysis utilizing the optimal alignment for each algorithm results in only
a small di↵erence in the AUC for the SIFT algorithm increasing from 78 to 79%.
3.2 Disagreement Among Predictions of Functionality
Chan et al. (2007) compared four methods: SIFT, Align-GVGD, PolyPhen and the
BLOSUM62 matrix, using the native alignments supplied by the program or manually
curated for Align-GVGD. In the paper each method individually had a limited overall
predictive value (72.9-82.0%), but when all four methods agree (62.7%), the overall
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predictive value increased to 88.1%. Karchin et al. (2009) argued these algorithms
have major similarities underneath the lid of each method and the correlation of
their outputs is the result of similarity of their inputs, which is not a cause for
increased confidence. Chun and Fay (2009) suggested di↵erences between missense
predictions from the algorithms may be due to di↵erences in the sequences and/or
alignments used to identify evolutionary conserved mutations. We directly tested
this idea by comparing the predictions of the SIFT, Align-GVGD and PolyPhen-2
algorithms by supplying the same four alignments to each algorithm. Surprisingly
we found a given algorithm did not necessarily perform best using the alignment
provided by the creator of the algorithm. For example, the PolyPhen-2 algorithm
reported higher sensitivities in all four genes using alignments other than its own
and SIFT had a slightly higher AUC when provided the Align-GVGD alignment
containing only orthologs as originally predicted by Ng and Heniko↵ (2002). The three
algorithms SIFT, PolyPhen-2 and Xvar all had a high sensitivity, but low specificity
implying these algorithms may overcall neutral variants deleterious. This feature
was most pronounced for Xvar with higher sensitivities and lower specificities than
most of the other algorithms. We showed Align-GVGD was the most a↵ected by
alignment employed, performing well when using manually curated alignments, but
calling all variants neutral when alignments contain a large number of sequences.
Thus, for large-scale sequencing experiments Align-GVGD would require development
of alignments with orthologous sequences through evolution for all genes. Conversely,
the PolyPhen-2 algorithm was shown to be the least sensitive to alignment provided
with nearly overlapping ROC curves. The ROC analysis resulted in AUC values of 78-
79% for all four algorithms using native alignments and 79% when using the optimal
alignment for each algorithm which shows despite the di↵erences in predictions from
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the algorithms and alignments the overall performance of these four commonly used
methods is similar.
Figure 3.4 : Predictions of neutral and deleterious mutations with the SIFT, Align-
GVGD, and PolyPhen-2 algorithms using the Align-GVGD alignment and the Xvar
algorithm using its own alignment. We also depict the exclusive overlap of the predic-
tions between the four algorithms to show their agreement (dark yellow) and between
the three algorithms SIFT, Align-GVGD, and PolyPhen-2 (light yellow).
Karchin et al. (2009) further argued that when the outputs from the algorithms
SIFT and PolyPhen di↵er, it is more likely due to using di↵erent protein sequence
alignments compared to the di↵erences in scores used to classify the variants. From
our experimental design, we were able to directly test this hypothesis. Using a Venn
diagram we depict the disjoint classification of variants predicted deleterious and neu-
tral in Figure 3.4, respectively by di↵erent algorithms all employing the Align-GVGD
alignment (as all three algorithms performed well with this alignment). When consid-
ering the predicted deleterious mutations the four algorithms agree on 195 mutations
(77%) using the Align-GVGD alignment, but the SIFT, Align-GVGD and PolyPhen-2
algorithms agree on an additional three mutations for a total of 198 mutations (79%).
Of this 195 only 181 are actually classified as deleterious by the LSDB. Interestingly,
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Chun and Fay (2009) compared the predicted deleterious mutations from the three
algorithms SIFT, PolyPhen and Likelihood Ratio Test (LRT) resulting in a very low
overlap of 5%, but when we perform a similar analysis employing the algorithms’ own
alignment, we see a much higher overlap of 70%. When considering the predicted
neutral mutations, the four algorithms only agree on 15 mutations (20%); excluding
Xvar results in agreement for another 13 mutations for a total of 28 mutations (39%)
which again demonstrates problems in predicting variants to be neutral. Only 11 of
the 15 variants are classified as neutral by the LSDB implying even when provided
the same alignment the algorithms make di↵erent predictions. Further research is
needed to understand the underlying di↵erences in these algorithms. Thus, in order
to predict missense mutation functionality, the researcher should consider optimizing
both the algorithm and sequence alignment employed.
3.3 Discussion
As we have shown in this chapter, predicting the impact of missense mutations on pro-
tein function depends on the algorithm used, the type of sequence alignment provided,
and on the number of sequences in the alignment leading to multiple interpretations
for each mutation. In addition to problems of interpretation there are technical di -
culties as well. In our experience, when simply submitting a list of missense mutations
to an algorithm the user must be able to: (1) manipulate the input format specified
by each algorithm, (2) build an optimal protein sequence alignment, if required, (3)
be knowledgeable of Unix system commands, (4) interpret server error messages, and
(5) transform the output to a working format for further studies. Standard input and
output formats are needed to alleviate the burden on the user. Also, tools to create
informative protein sequence alignments for each protein are necessary to accurately
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predict the impact of missense mutations on protein function. An additional source of
error in prediction when analyzing sequence variants identified through disease status
is that all algorithms focus on the missense change encoded by the variant when in
reality the sequence variant may also impact gene expression for example through
alternative splicing of the messenger RNA.
Finally, great caution should be taken when comparing the accuracy of new in
silico methods. A recent article [Acharya and Nagarajaram, 2012] was published de-
scribing a new method called Hansa, which classifies missense mutations into neutral
and deleterious categories. However, the authors did not provide su cient details
about their algorithm, which resulted in a number of concerns about the appropriate-
ness and application of statistical methods that compare Hansa with existing algo-
rithms. The authors stated their method outperformed other known methods such as
PolyPhen-2 and SIFT by comparing the ROCs of Hansa to the ROCs of the other al-
gorithms. In their Table 2, a direct comparison of the ROCs was made by employing a
benchmark dataset called HumVar originally described in Capriotti et al. (2006) and
employed in Adzhubei et al. (2010), which compares the true positive rates between
algorithms for a fixed false positive rate. As shown in this chapter, ROCs require a
probability or continuous score associated with each prediction to compute TPRs and
FPRs as the discrimination threshold is varied [Pepe, 2004]. For example, the ROC
of PolyPhen-2 was based on the naive Bayes probability provided by the algorithm
itself and the ROC of SIFT was based on the SIFT score [Adzhubei et al., 2010].
As described in the publication, Hansa is based on support vector machine (SVM)
method, which uses a set of 10 discriminatory features to classify missense mutations
as neutral or deleterious. SVMs are nonprobabilistic classifiers [Hastie et al., 2009],
and consistently, there is no probability or continuous score associated with each
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prediction, and thus, an ROC analysis does not seem obviously feasible for this algo-
rithm. In the publication, there is no mention of what continuous score or probability
was used to calculate the TPRs of Hansa for a fixed FPR. Therefore, it is unclear
how they might attain various TPRs for a given FPR because there is no varying
threshold defined.
We compared Hansa with other algorithms using the independent data set of n =
267 mutations from cancer-associated genes [Hicks et al., 2011], which Acharya and
Nagarajaram (2012) use as a validation data set to the HumVar data that Hansa
was trained on. We originally used this well-characterized data to compare the TPRs
and FPRs of several algorithms using their native protein sequence alignments and to
evaluate the impact of the predictions when the algorithms were supplied other align-
ments. Because Hansa does not provide a probability or continuous score associated
with each prediction, we could not provide the ROC curves and could only calculate
the TPRs and FPRs for each algorithm. Hansa seems to perform comparably to the
other algorithms (Figure 3.5).
In addition, as a way to compare the improvement of TPR in Hansa over the other
algorithms, the authors inappropriately performed a paired t-test. Because they are
comparing proportions, it would be preferable to use for example a test for a di↵erence
in proportions with a correction for multiple testing. Furthermore, to measure the
performance of the SVM, the authors state they use a n-fold cross-validation and
leave-one-out cross-validation (LOOCV) to assess the generalization and stability of
their method. Unfortunately, they do not report the parameter estimates of the SVM
and do not report the n-fold cross-validation error. They only report a LOOCV error,
which makes it di cult to assess the validity of this analysis. In summary, a thorough
statistical assessment is needed when comparing these in silico algorithms.
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Figure 3.5 : Predictions from the following four algorithms were taken from dbNSFP
[Liu et al., 2011]: Likelihood Ratio Test (LRT), Mutation Taster, PolyPhen-2, and
SIFT; predictions from the last two algorithms were produced on their respective web
pages: Hansa [Acharya and Nagarajaram, 2012] and Xvar [Reva et al., 2011].
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Chapter 4
A New Method for Interpreting the Functionality
of Missense Mutations
Thousands of missense mutations with unknown biological significance are reported
by genome-scale sequencing projects. As shown in Chapter 3, many computational
or in silico methods have been developed to predict the functionality of missense mu-
tations, but surprisingly there is a high degree of disagreement among the predictions
produced by these methods even though the majority of these methods base their pre-
dictions on similar information (the use of evolutionary conservation as a measure of
pathogenicity). These discordant functional predictions often leave researchers with-
out guidance in how to prioritize the mutations identified for further evaluation in
biological functional assays. In this chapter, we develop two statistical models based
on the capture-recapture paradigm which combine the discordant functional predic-
tions in a statistically rigorous manner and estimate a unified posterior probability of
functionality or pathogenicity for each missense mutation. Unlike previous methods,
our probabilistic approach requires no training set or calibration and estimates the
accuracy (sensitivity and specificity) of each individual in silico method in the ab-
sence of a gold standard by taking advantage of the fact these methods disagree. In
Section 4.2, we develop two models referred to as postMUT and postMUT (simple)
and derive the parameter estimates for the Expectation-Maximization algorithm. In
Section 4.3, we give several applications such as we show our estimates of sensitivity
and specificity of the in silico algorithms (without employing a gold standard) match
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the estimates of sensitivity and specificity when a gold standard is available. The
posterior probability of pathogenicity introduced in this chapter is a statistical tool
scalable to the exome which may be used to infer the functionality of missense mu-
tations and can be easily incorporated in downstream analyses such as disease gene
prioritization tools ultimately inferring candidate genes.
4.1 Combining Discordant Predictions of Missense Mutation
Functionality using Capture-Recapture Methods
Determining the consequences of genetic variation is a major challenge in bioinfor-
matics and genomics. It is estimated each individual genome di↵ers from a reference
genome at 3.0-3.5 million variants whereas each individual exome di↵ers at 20,000-
30,000 variants of which 10,000 are predicted to be nonsynonymous changes, splice
site changes or indels [Robinson et al., 2011, Gonzaga-Jauregui et al., 2012]. Inter-
preting the functional consequences of these nonsynonymous changes is an important
step in identifying and determining the clinical importance of disease susceptibility
mutations. In particular, the interpretation of missense mutations (point mutation in
which a single nucleotide is changed resulting in amino acid change) has remained a
di cult task because missense mutations do not necessarily impact protein function.
Many computational or in silico algorithms have been developed to predict the im-
pact of missense mutations on protein function. Several reviews of these methods are
available [Mooney, 2005, Ng and Heniko↵, 2006, Karchin, 2009, Thusberg and Vihinen, 2009,
Jordan et al., 2010, Thusberg et al., 2011]. In general, these methods can be classi-
fied into three groups: first-principles methods, trained classifiers or genomic annota-
tion tools [Cooper and Shendure, 2011]. The majority of first-principles methods and
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trained classifiers use protein sequence alignments as input because they are based
on a similar idea of using evolutionary conservation or a combination of phylogenetic
information with protein structure or other sequence annotations as a measure of
the pathogenic e↵ect of missense mutations on protein function [Jordan et al., 2010].
We have previously shown predictions from these in silico methods are highly depen-
dent on the input parameters used in each algorithm (such as phylogenic scope and
quality of the protein sequence alignments) and make di↵erent predictions even when
provided the same protein sequence alignment [Hicks et al., 2011].
A major problem with these in silico methods is there is a high degree of dis-
agreement among the functional predictions even though these methods rely on sim-
ilar evolutionary information to assess functionality. Several studies have investi-
gated the agreement of predicted deleterious missense mutations between these meth-
ods and report varying estimates ranging from 3.5% to 77% [Chun and Fay, 2009,
Ja↵e et al., 2011, Hicks et al., 2011, Gray et al., 2012]. This suggests the functional
predictions produced from these in silico methods may be context-dependent (mis-
sense mutations play di↵erent roles in di↵erent diseases and therefore their functional
e↵ect may vary) and mutation set-dependent (certain methods may be calibrated to
perform more accurately on specific sets of mutations).
Some previously proposed solutions referred to as umbrella methods [Sunyaev, 2012]
or consensus tools such as Condel [Gonza´lez-Pe´rez and Lo´pez-Bigas, 2011] or Carol
[Lopes et al., 2012] have been developed to combine the functional predictions from
these algorithms based on some weighted average of scores from the individual in silico
methods. The problem with these approaches is they do not account for the sensi-
tivity (probability of calling the variant deleterious if it is deleterious) or specificity
(probability of calling the variant neutral if it is neutral) of each method and do not
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seem to be based on rigorous statistical principles. Others have combined functional
predictions using logistic regression [Thompson et al., 2013], but this requires a gold
standard or set of mutations with known functionality to estimate the coe cients in
the regression model. This approach is not immediately scalable to the exome because
it requires individual calibration for each gene and requires the use of locus-specific
databases (LSDBs) or manually curated collections of sequence variants associated
with diseases. Because validated exome-scale LSDBs are not available, most groups
use sets of mutations only weakly associated with disease, but this leads to possible
biases in comparisons between in silico methods.
In this chapter, we take a maximum likelihood based approach [Lehmann and Casella, 1998,
Shao, 2003] to combine the discordant functional predictions in a statistically rigorous
manner and to estimate a unified posterior probability of functionality or pathogenic-
ity for each missense mutation. Unlike previous methods, our approach, referred to as
postMUT and postMUT (simple), requires no training set or calibration and estimates
the sensitivity and specificity of each individual in silico method in the absence of a
gold standard by taking advantage of the fact these methods disagree. The idea is bor-
rowed from the technique named capture-recapture [Otis et al., 1978, Pollock, 1982]
which originated in ecology as a way to estimate population sizes. When gold stan-
dards or sets of mutations with known functionality are available, researchers may
use these to fine-tune parameters such as evolutionary depth of the protein sequence
alignments as input to the prediction algorithms and to optimize performance of the
algorithm. To test the validity of this approach we show our estimates of sensitivity
and specificity of the in silicomethods (without employing a gold standard) match the
estimates of sensitivity and specificity when a gold standard is available. These pos-
terior probabilities of pathogenicity for missense mutations introduced in this chapter
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may be used to further prioritize the mutations identified for evaluation in biologi-
cal functional assays and can be incorporated in downstream analyses of exome-scale
datasets such as disease gene prioritization tools ultimately inferring candidate genes.
4.2 Bernoulli Mixture Models: A Maximum Likelihood Ap-
proach
The postMUT and postMUT (simple) models are defined as mixtures of Bernoulli
probability distributions with the weight parameter representing the overall propor-
tion of deleterious mutations in a given set. The main principle of the postMUT
(simple) model is that a given missense mutation can be defined as having a func-
tional or neutral e↵ect on protein function. These two exclusive possibilities are
correspondingly coded as Y = 1 and Y = 0. Y is a latent (unobservable) variable.
Given Y , each jth in silico method calls the variant functional or neutral (coded as
Xj = 1 and Xj = 0) with di↵erent Y -dependent probabilities. These outcomes are
observable. Somewhat surprisingly, these observations are frequently su cient for
estimation of the probabilities of Y = 1 and the probabilities of Xj = 1 and Xj = 0
given Y .
If we consider n in silico methods, then we may separate a set of mutations into
disjoint classes or categories depending on which mutations are predicted deleteri-
ous (or neutral) by each method to depict the overlap or agreement between the
methods. We previously provided an example of these disjoint classes (Hicks et al.
2011). Figure 4.1 gives two examples of Venn diagrams depicting the disjoint classes
of mutations predicted deleterious by three commonly employed algorithms (SIFT,
PolyPhen-2 and MutationAssessor) on two gold standard databases HumDiv and
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HumVar. An important technical point is that we use terms functional and deleteri-
ous interchangeably to represent mutations that have a damaging e↵ect on molecular
function resulting in a negative e↵ect on the fitness such as a loss of protein function
in tumor suppressor genes or a gain of function in oncogenes [Sunyaev, 2012].
Figure 4.1 : Venn diagram of the number of mutations predicted deleterious from
SIFT, MutationAssessor and PolyPhen-2 using: (A) mutations from HumDiv and
(B) mutations from HumVar. The number outside the Venn diagrams represent the
number of predicted neutral mutations by all three algorithms.
4.2.1 Formal Definition of Model
Formally, we define each missense mutation in a dataset (e.g. missense mutations
reported from an individual exome) to have either a “deleterious” or a “neutral”
e↵ect on protein function. Consider a set of m mutations and n algorithms. Let
Y = (Y1, . . . , Ym) denote the “gold standard” or true functional status of the m
64
mutations where
Yi =
8><>: 1 if ith mutation is truly deleterious0 if ith mutation is truly neutral
If a gold standard is available, we can simply calculate the sensitivity and specificity
for each algorithm directly. Because gold standards are not widely available, Yi is
considered a latent variable or missing information. Instead, we only observe the
predictions of functionality from the various in silico methods which we refer to as X.
Let X = (X1, . . . ,Xn) denote a set of predictions of missense mutation functionality
from n methods where
Xij =
8><>: 1 if ith mutation is predicted deleterious0 if ith mutation is predicted neutral
In silico methods often produce a continuous probability or score associated with
each binary functional prediction. We do not use these continuous values, but we are
interested in extending these models to incorporate them to improve the accuracy.
To assess the degree of disagreement between the methods, disjoint categories of
mutations predicted deleterious (or neutral) are calculated using Xij. If there are
n methods, then there are 2n categories that the ith mutation could fall into. For
example, Tables 4.1 and 4.2 are examples of how to label the 4 and 8 disjoint categories
from n = 2 and n = 3 algorithms, respectively, which depend on the joint functional
predictions Xi from the ith mutation.
Let N(k) be the number of mutations in the kth category where
N(k) =
mX
i=1
I[K(Xi)=k] (4.1)
and I[K(Xi)=k] is an indicator function for the kth category. We note the expecta-
tion E(I[K(Xi)=k]) is the probability of the ith mutation being in the kth category
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Table 4.1 : Example labels for disjoint categories (1, . . . , 2n) which depend on the
joint predictions Xi from using n = 2 in silico methods.
Xi1 Xi2 Category
0 0 K(Xi) = 1
1 0 K(Xi) = 2
0 1 K(Xi) = 3
1 1 K(Xi) = 4
Table 4.2 : Example labels for the 2n disjoint categories which depend on the joint
predictions Xi = (Xi1, Xi2, Xi3) from using n = 3 algorithms.
Xi1 Xi2 Xi3 Category
0 0 0 K(Xi) = 1
0 0 1 K(Xi) = 2
0 1 0 K(Xi) = 3
1 0 0 K(Xi) = 4
0 1 1 K(Xi) = 5
1 0 1 K(Xi) = 6
1 1 0 K(Xi) = 7
1 1 1 K(Xi) = 8
P (K(Xi) = k) which uses the functional predictions corresponding to the kth cate-
gory Xi = K 1(k) (will be further discussed in Section 4.2.2).
Conditional on the true functional mutation status Yi, we assume each jth method
will predict the functionality of the ith mutation with a di↵erent sensitivity (probabil-
ity of identifying true deleterious mutations) and specificity (probability of identifying
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true neutral mutations). Therefore, we define the parameters
aj = P (Xij = 1|Yi = 0)
bj = P (Xij = 1|Yi = 1)
p = P (Yi = 1)
where aj can be interpreted as the probability of a false positive (or incorrectly pre-
dicting the mutation to be deleterious) for the jth method, bj can be interpreted as
the probability of a true positive (correctly predicting a deleterious mutation) for the
j method and p is the probability of a deleterious mutation.
Next, we develop two statistical models referred to as postMUT (simple) and
postMUT which are both mixtures of Bernoulli distributions. These models jointly
estimate the sensitivity and specificity of each individual in silico method and the
overall proportion of deleterious mutations.
4.2.2 Model Formulation
postMUT (simple) Model
The probability of observing the functional prediction for the ith mutation from the
jth algorithm is
P (Xij = xij) = P (Xij = xij|Yi = 0)P (Yi = 0) + P (Xij = xij|Yi = 1)P (Yi = 1)
= a
xij
j (1  aj)(1 xij)(1  p) + bxijj (1  bj)(1 xij)p
with unknown parameters ✓ = (a1, . . . , an, b1, . . . , bn, p). If we assume conditional
independence between n algorithms given knowledge of the true functionality for
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each ith mutation, then the joint likelihood of Xi can be written as
PXi = P[Xi|Yi=0]P[Yi=0] + P[Xi|Yi=1]P[Yi=1]
=
nY
j=1
P[Xij |Yi=0]P[Yi=0] +
nY
j=1
P[Xij |Yi=1]P[Yi=1]
If we consider m mutations, we can re-write the likelihood using the number of mu-
tations in the kth category, N(k), which is defined in (4.1). Then, the observed data
likelihood is given by
L(✓|N) =
2nY
k=1
Ck(P[K(Xi)=k])
N(k) (4.2)
where Ck = (
N !
N(x)(1)!···N(x)(2n)!) and P[K(Xi)=k] = PXi using the Xi = K
 1(k) values
corresponding to the kth category.
Because maximum likelihood estimation cannot be directly applied with latent
variables, we assume we know the latent variable Yi and employ the Expectation-
Maximization algorithm [Dempster et al., 1977]. We note N(k) can be written as
N(k) = u(k) + v(k)
where
u(k) =
mX
i=1
I[Yi=0]I[K(Xi)=k]
v(k) =
mX
i=1
I[Yi=1]I[K(Xi)=k]
yielding the complete data likelihood:
L0(✓|N, v)=
2nY
k=1
Ck[P[Xi|Yi=0]P[Yi=0]]
u(k)[P[Xi|Yi=1]P[Yi=1]]
v(k) (4.3)
using the Xi = K 1(k) values corresponding to the kth category. We note it is
su cient to define the complete data likelihood in terms of (N, u) or (N, v) because
68
u = N   v and the observed data likelihood can be written as a summation over all
possible v(k).
L(✓|N) =
X
v
✓
N(k)
v(k)
◆
L0(✓|N, v)
postMUT Model
We extend postMUT (simple) by introducing a second latent variable Z = (Z1, . . . , Zm)
in addition to Xij and Yi. Zi corresponds to information about the functionality of
the ith mutation that is contained in the protein sequence alignment. Let
Zi =
8><>: 1 if the alignment is informative0 if the alignment is not informative
An example of an informative alignment would be a manually curated alignment
containing mostly orthologues (genes derived from speciation events) as opposed to
mostly paralogues (genes derived from duplication events). Consider two alignments
for the ith mutation from the algorithms: Algorithm A, Algorithm B. Assume both
alignments created show mutation i is highly conserved. If Algorithm A produces
alignments more ‘informative’ (e.g. type of homolog used in the alignment) than
Algorithm B, then the probability that the mutation will be predicted deleterious by
Algorithm A (conditional on Zi) is higher than the probability the mutation will be
predicted deleterious by Algorithm B (conditional on Zi).
With this in mind, we define a new model which again is a mixture of Bernoulli
distributions, but with parameters ✓ = (d1, . . . , dn, e1, . . . , en,  ,  , p) where
dj = P (Xij = 1|Zi = 0), ej = P (Xij = 1|Zi = 1)
  = P (Zi = 0|Yi = 0),   = P (Zi = 1|Yi = 1)
p = P (Yi = 1)
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Though the addition of the latent variable Zi does increase the number of pa-
rameters, we will show it adds flexibility to estimation. We assume conditional inde-
pendence between n algorithms given knowledge of Zi (as opposed to the postMUT
(simple) model which assumes conditional independence between algorithms given
knowledge of Yi), then the joint likelihood of Xi can be written as
PXi = P[Xi|Zi=0]P[Zi=0|Yi=0]P[Yi=0] + P[Xi|Zi=0]P[Zi=0|Yi=1]P[Yi=1]
+ P[Xi|Zi=1]P[Zi=1|Yi=0]P[Yi=0] + P[Xi|Zi=1]P[Zi=1|Yi=1]P[Yi=1]
We can write the likelihood using the number of mutations in the kth category,
N(k) using (4.2) but P[K(Xi)=k] = PXi from the postMUT model using the Xi =
K 1(k) values corresponding with the kth category.
Assuming we know the latent variables Zi and Yi, we can write N(k) as
N(k) = r(k) + u(k) + v(k) + w(k)
where
r(k) =
mX
i=1
I[Zi=0]I[Yi=0]I[K(Xi)=k]
u(k) =
mX
i=1
I[Zi=0]I[Yi=1]I[K(Xi)=k]
v(k) =
mX
i=1
I[Zi=1]I[Yi=0]I[K(Xi)=k]
w(k) =
mX
i=1
I[Zi=1]I[Yi=1]I[K(Xi)=k]
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yielding the complete data likelihood
L0(✓|N, u, v, w)=
2nY
k=1
Ck[P[Xi|Zi=0]P[Zi=0|Yi=0]P[Yi=0]]
r(k)
⇥ [P[Xi|Zi=0]P[Zi=0|Yi=1]P[Yi=1]]u(k)
⇥ [P[Xi|Zi=1]P[Zi=1|Yi=0]P[Yi=0]]v(k)
⇥ [P[Xi|Zi=1]P[Zi=1|Yi=1]P[Yi=1]]w(k)
using the Xi = K 1(k) values corresponding to the kth category. We note it is
su cient to define the complete data likelihood in terms of (N, u, v, w) because r =
N  u  v w. Similar to the postMUT (simple) model, the observed data likelihood
can be written as a sum over all possible u(k), v(k), w(k).
To estimate the sensitivity (bj) and 1-specificity (aj) for each jth algorithm, we
compute the marginal probabilities
aj = dj  + ej(1   ) (4.4)
bj = dj(1   ) + ej  (4.5)
4.2.3 Parameter Estimation using EM Algorithm
We used the Expectation-Maximization (EM) algorithm [Dempster et al., 1977] to es-
timate the unknown parameters ✓. First, we compute the expectation of the logarithm
of the complete data likelihood with respect to v|N, ✓0 followed by the maximization
with respect to ✓.
postMUT (simple) Model
Expectation Step
In Equation 4.3, we provided the complete data likelihood L0(✓|v). The logarithm of
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the complete data likelihood is given by
logL0(✓|N, v) = log
2nY
k=1
Ck[
nY
j=1
P[Xij |Yi=0]P[Yi=0]]
(N(k) v(k))[
nY
j=1
P[Xij |Yi=1]P[Yi=1]]
v(k)
= log(CK)
+
X
k
[(N(k)  v(k)){
X
j
xij log(aj) + (1  xij) log(1  aj) + log(1  p)}
+ v(k){
X
j
xij log(bj) + (1  xij) log(1  bj) + log(p)}]
We note
Ev|N,✓0 [v(k)] = Ev|N,✓0 [
mX
i=1
I[Yi=1]I[K(Xi)=k]] =
mX
i=1
P [Yi = 1|N, ✓0 ]I[K(Xi)=k] = ⇡(xi)N(k)
where
⇡(xi) = P [Yi = 1|N, ✓0 ]
=
Qn
j=1(b
0
j)
xij(1  b0j)(1 xij)p0Qn
j=1(a
0
j)
xij(1  a0j)(1 xij)(1  p0) +
Qn
j=1(b
0
j)
xij(1  b0j)(1 xij)p0
using the xi = K 1(k) values associated with the kth category and ✓
0
= (a
0
1, . . . , a
0
n, b
0
1, . . . , b
0
n, p
0
)
which are the parameter estimates at the previous iteration in the EM algorithm.
Next, the expectation of the logarithm of the complete data likelihood (Equation 4.3)
with respect to v|N, ✓0
Q(✓|✓0) = Ev|N,✓0 [logL0(✓|N, v)]
= log(CK)
+
X
k
(N(k)  Ev|N,✓0 [v(k)]){
X
j
xij log(aj) + (1  xij) log(1  aj) + log(1  p)}
+ Ev|N,✓0 [v(k)]{
X
j
xij log(bj) + (1  xij) log(1  bj) + log(p)}
= log(CK) +
X
k
N(k)[(1  ⇡(xi)){
X
j
xij log(aj) + (1  xij) log(1  aj) + (1  p)}
+ ⇡(xi){
X
j
xij log(bj) + (1  xij) log(1  bj) + p}]
72
where xi = K 1(k) are values associated with the kth category
Maximization Step
Maximize Q(✓|✓0) with respect to ✓ = (a1, . . . , an, b1, . . . , bn, p)
@Q
@p
=  
X
k
N(k)(1  ⇡(xi)) 1
1  p +
X
k
N(k)⇡(xi)
1
p
Setting @Q@p = 0 and solving for p yields
pˆ =
P
kN(k)⇡(xi)P
kN(k)
where xi = K 1(k) are values associated with the kth category.
Similarly,
@Q
@aj
=
X
k
N(k)(1  ⇡(xi))[xij
aj
  (1  xij)
(1  aj) ]
@Q
@bj
=
X
k
N(k)⇡(xi)[
xij
bj
  (1  xij)
(1  bj) ]
Setting @Q@aj = 0,
@Q
@bj
= 0 and solving for aj, bj yields
aˆj =
P
kN(k)(1  ⇡(xi))xijP
kN(k)(1  ⇡(xi))
bˆj =
P
kN(k)⇡(xi)xijP
kN(k)⇡(xi)
where xi = K 1(k) are values associated with the kth category.
Using these parameter estimates ✓ˆ, we compute the posterior probability for the
ith mutation being deleterious in the postMUT (simple) model considering all the
joint observed functional predictions Xi from the n algorithms:
P (Yi = 1|Xi) = P (Xi|Yi = 1)P (Yi = 1)
P (Xi)
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postMUT Model
We used the Expectation-Maximization algorithm [Dempster et al., 1977] again for
parameter estimation of ✓.
Expectation Step
We provided the complete data likelihood L0(✓|u, v, w) (= L0 for short). The loga-
rithm of the complete data likelihood is given by
logL0= log
2nY
k=1
CK [
nY
j=1
P[Xij |Zi=0]P[Zi=0|Yi=0]P[Yi=0]]
(N(k) u(k) v(k) w(k))
⇥ [
nY
j=1
P[Xij |Zi=0]P[Zi=0|Yi=1]P[Yi=1]]
u(k)
⇥ [
nY
j=1
P[Xij |Zi=1]P[Zi=1|Yi=0]P[Yi=0]]
v(k)
⇥ [
nY
j=1
P[Xij |Zi=1]P[Zi=1|Yi=1]P[Yi=1]]
w(k)
= log(CK)
+
X
k
[(N(k)  u(k)  v(k)  w(k)){
⇥
X
j
xij log(dj) + (1  xij) log(1  dj) + log( ) + log(1  p)}
+ u(k){
X
j
xij log(dj) + (1  xij) log(1  dj) + log(1   ) + log(p)}
+ v(k){
X
j
xij log(ej) + (1  xij) log(1  ej) + log(1   ) + log(1  p)}
+ w(k){
X
j
xij log(ej) + (1  xij) log(1  ej) + log( ) + log(p)}]
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We note
Eu|N,v,w,✓0 [u(k)] =
mX
i=1
P [Zi = 0, Yi = 1|N, ✓0 ]I[K(Xi)=k] = ⇡u(xi)N(k)
Ev|N,u,w,✓0 [v(k)] =
mX
i=1
P [Zi = 1, Yi = 0|N, ✓0 ]I[K(Xi)=k] = ⇡v(xi)N(k)
Ew|N,u,v,✓0 [w(k)] =
mX
i=1
P [Zi = 1, Yi = 1|N, ✓0 ]I[K(Xi)=k] = ⇡w(xi)N(k)
where
⇡u(xi) = P [Zi = 0, Yi = 1|N, ✓0 ]
=
Qn
j=1(d
0
j)
xij(1  d0j)(1 xij)(1    0)p0Qn
j=1(d
0
j)
xij(1  d0j)(1 xij)(1  p⇤) +
Qn
j=1(e
0
j)
xij(1  e0j)(1 xij)p⇤
⇡v(xi) = P [Zi = 1, Yi = 0|N, ✓0 ]
=
Qn
j=1(e
0
j)
xij(1  e0j)(1 xij)(1   0)(1  p0)Qn
j=1(d
0
j)
xij(1  d0j)(1 xij)(1  p⇤) +
Qn
j=1(e
0
j)
xij(1  e0j)(1 xij)p⇤
⇡w(xi) = P [Zi = 1, Yi = 1|N, ✓0 ]
=
Qn
j=1(e
0
j)
xij(1  e0j)(1 xij)  0p0Qn
j=1(d
0
j)
xij(1  d0j)(1 xij)(1  p⇤) +
Qn
j=1(e
0
j)
xij(1  e0j)(1 xij)p⇤
with p⇤ = (1   0)(1  p0)+  0p0 using the xi = K 1(k) values associated with the kth
category and ✓
0
= (d
0
1, . . . , d
0
n, e
0
1, . . . , e
0
n,  
0
,  
0
, p
0
) which are the parameter estimates
at the previous iteration in the EM algorithm. Next, the expectation of the logarithm
of the complete data likelihood with respect to u, v, w|N, ✓0
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Q(✓|✓0) = Eu,v,w|N,✓0 [logL0(✓|N, u, v, w)]
= log(CK) +
X
k
[(N(k)  Eu|N,✓0 [u(k)]  Ev|N,✓0 [v(k)]  Ew|N,✓0 [w(k)])
⇥ {
X
j
xij log(dj) + (1  xij) log(1  dj) + log( ) + log(1  p)}
+ Eu|N,✓0 [u(k)]{
X
j
xij log(dj) + (1  xij) log(1  dj) + log(1   ) + log(p)}
+ Ev|N,✓0 [v(k)]{
X
j
xij log(ej) + (1  xij) log(1  ej) + log(1   ) + log(1  p)}
+ Ew|N,✓0 [w(k)]{
X
j
xij log(ej) + (1  xij) log(1  ej) + log( ) + log(p)}]
= log(CK) +
X
k
N(k)[(1  ⇡u(xi)  ⇡v(xi)  ⇡w(xi))
⇥ {
X
j
xij log(dj) + (1  xij) log(1  dj) + log( ) + log(1  p)}
+ ⇡u(xi){
X
j
xij log(dj) + (1  xij) log(1  dj) + log(1   ) + log(p)}
+ ⇡v(xi){
X
j
xij log(ej) + (1  xij) log(1  ej) + log(1   ) + log(1  p)}
+ ⇡w(xi){
X
j
xij log(ej) + (1  xij) log(1  ej) + log( ) + log(p)}]
where xi = K 1(k) are values associated with the kth category.
Maximization Step
Maximize Q(✓|✓0) with respect to ✓ = (d1, . . . , dn, e1, . . . , en,  ,  , p)
@Q
@p
=  
X
k
N(k)(1  ⇡u(xi)  ⇡v(xi)  ⇡w(xi)) 1
1  p +
X
k
N(k)⇡u(xi)
1
p
 
X
k
N(k)⇡v(xi)
1
1  p +
X
k
N(k)⇡w(xi)
1
p
Setting @Q@p = 0 and solving for p yields
pˆ =
P
kN(k)(⇡u(xi) + ⇡w(xi))P
kN(k)
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where xi = K 1(k) are values associated with the kth category.
Similarly,
@Q
@ 
=
X
k
N(k)(1  ⇡u(xi)  ⇡v(xi)  ⇡w(xi))1
 
 
X
k
N(k)⇡v(xi)
1
1   
@Q
@ 
=  
X
k
N(k)⇡u(xi)
1
1    +
X
k
N(k)⇡w(xi)
1
 
Setting @Q@  = 0,
@Q
@  = 0 and solving for  ,   yields
 ˆ =
P
kN(k)(1  ⇡u(xi)  ⇡v(xi)  ⇡w(xi))P
kN(k)(1  ⇡u(xi)  ⇡w(xi))
 ˆ =
P
kN(k)⇡w(xi)P
kN(k)(⇡u(xi) + ⇡w(xi))
where xi = K 1(k) are values associated with the kth category.
Finally,
@Q
@dj
=
X
k
N(k)(1  ⇡v(xi)  ⇡w(xi))[xij
dj
  (1  xij)
(1  dj) ]
@Q
@ej
=
X
k
N(k)(⇡v(xi) + ⇡w(xi))[
xij
ej
  (1  xij)
(1  ej) ]
Setting @Q@dj = 0,
@Q
@ej
= 0 and solving for dj, ej yields
dˆj =
P
kN(k)(1  ⇡v(xi)  ⇡w(xi))xijP
kN(k)(1  ⇡v(xi)  ⇡w(xi))
eˆj =
P
kN(k)(⇡v(xi) + ⇡w(xi))xijP
kN(k)(⇡v(xi) + ⇡w(xi))
where xi = K 1(k) are values associated with the kth category.
Using these parameter estimates ✓ˆ, the posterior probability can be calculated for
the ith mutation being deleterious in the postMUT model considering all the joint
observed functional predictions Xi from the n algorithms:
P (Yi = 1|Xi)= P (Xi|Yi = 1)P (Yi = 1)
P (Xi)
=
P (Xi, Zi = 0|Yi = 1)P (Yi = 1) + P (Xi, Zi = 1|Yi = 1)P (Yi = 1)
P (Xi)
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4.2.4 Confidence Intervals and Wald Confidence Regions
A 100(1   ↵)% Wald confidence regions [Wald, 1943] of the joint sensitivity and
specificity for each jth algorithm (creating an ellipsoid boundary) are also computed
using Fisher’s information [Shao, 2003] using asymptotic tests based on likelihoods.
We note there are two other asymptotic tests discussed in (Likelihood-ratio test, Rao’s
score test) which are all asymptotically equivalent to using the Wald test to compute
the confidence regions.
To calculate a 100(1   ↵)% confidence interval for ✓, Oakes (1999) showed it
was su cient to use the function Q(✓|✓0) when calculating the observed information
matrix where
I(✓) =  @
2Q
@✓2
|✓=✓ˆ
yielding the formula
[✓ˆ   Z1 ↵/2( 1p
I(✓)
), ✓ˆ + Z1 ↵/2(
1p
I(✓)
)]
where ✓ˆ are the parameter estimates of ✓.
A 100(1 ↵)%Wald confidence region using Fisher’s information can be calculated
using the formulate
{✓ : (✓   ✓ˆ)TV  1(✓   ✓ˆ)   2p,1 ↵}
where
V  1 =   @
2Q
@✓@✓T
|✓=✓ˆ
and ✓ˆ are the parameter estimates of ✓.
4.3 Applications of Capture-Recapture Models
In this section, we obtain functional predictions from multiple in silico methods with
batch-input capabilities for a large number of mutations and apply our postMUT
78
models to several sets of human mutations (both with and without gold standards).
We show our estimates of sensitivity and specificity of the in silico methods (without
employing a gold standard) match the estimates of sensitivity and specificity when
a gold standard is available. Therefore, we are able to account for accuracy of each
in silico method when combining predictions of missense mutation functionality. In
this latter case, specificity is estimated by the frequency of correctly calling neutral
variants neutral and sensitivity is estimated by the frequency of correctly calling
deleterious variants deleterious. We also provide an interesting application of our
postMUT models which estimates the overall proportion of deleterious mutations
in a given set using mutations extracted from matched tumor/normal breast cancer
genomes.
In this study we used functional predictions from three groups of in silicomethods:
1. Methods with batch-input capabilities for a large number of mutations (such as
in whole exome sequencing) available on the methods website.
SIFT. [Ng and Heniko↵, 2001] We used the SIFT Batch Protein option avail-
able on the website. Mutations were classified as neutral and deleterious.
MutationAssessor. [Reva et al., 2011] We used the web-based version 1.0
with all default settings. Mutations predicted as neutral and low were classified
as neutral mutations and mutations predicted as medium and high were classi-
fied as deleterious mutations.
PolyPhen-2 HumDiv (HD). [Adzhubei et al., 2010] We used the PolyPhen-
2 classifier model HumDiv as it is the default option, but PolyPhen-2 HumVar
is also available on the website. Mutations predicted as neutral were classified
as neutral mutations and mutations predicted possibly damaging and probably
damaging were classified as deleterious mutations.
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2. dbNSFP. [Liu et al., 2011] We used dbNSFP version 2.0 released April 2012
which contains pre-computed predictions from SIFT, PolyPhen-2 HD and HV,
LRT and Mutation Taster. Because the default version on the PolyPhen-2
website is HD, we used PolyPhen-2 (HD) for this analysis and omitted the
predictions listed from PolyPhen-2 (HV).
3. Four methods described in Hicks et al. (2011). SIFT, PolyPhen-2 (HD), Align-
GVGD, MutationAssessor were used on the set of well-characterized mutations.
We used the functional predictions from each algorithm using the protein se-
quence alignment automatically generated by the algorithm or manually curated
for the algorithm.
All functional predictions were obtained on a Mac OS X 10.6.8 using Safari 5.1.7
except the predictions obtained for the well-characterized mutations which were pre-
viously described in Hicks et al. (2011). Estimation using the EM algorithm was
performed on the Shared University Grid at Rice (SUG@R). For more details related
to the identifiability of parameters when performing estimation, see McLachlan and
Peel (2000).
4.3.1 HumDiv and HumVar
The first two sets of mutations with known functionality we used are referred to as
‘HumDiv’ and ‘HumVar’. HumVar was first described in Capriotti et al. (2006) and
HumDiv was described in Adzhubei et al. (2010). HumVar consists of all human-
disease causing mutations extracted from UniProtKB and common (> 1%) human
mutations without disease annotations. To compare, HumDiv consists of damaging
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alleles causing Mendelian diseases and a↵ecting protein function and neutral muta-
tions found comparing human proteins with closely related homologs. Both sets of
mutations are freely available on the website provided by the authors of PolyPhen-2
[Adzhubei et al., 2010].
HumVar and HumDiv were used to train and test the nave bayes classifier used
by PolyPhen-2 [Adzhubei et al., 2010]. HumVar listed n = 21151 neutral and n =
22196 deleterious mutations, as opposed to HumDiv which listed n = 7539 neu-
tral and n = 5564 deleterious mutations. Considering the subset of mutations with
predictions obtained directly from the websites by all three in silico methods (SIFT,
MutationAssessor, PolyPhen-2), HumVar contained n = 18319 neutral and n = 19702
deleterious mutations and HumDiv contained n = 6755 neutral and n = 4978 delete-
rious mutations.
We previously showed in Figure 4.1 the Venn diagrams of the number of mutations
predicted deleterious by the three in silico methods SIFT, MutationAssessor and
PolyPhen-2 when using HumDiv and HumVar data sets, respectively. There is a
62.8% and 60.4% agreement of predicted frequency of deleterious mutations between
these methods in HumDiv and HumVar, respectively. Figure 4.2 depicts estimates of
the sensitivity and specificity of the in silico methods using the HumDiv and HumVar
data sets, respectively. Table 4.3 shows our estimates of sensitivity and specificity of
the in silico methods (estimated from the postMUT model without employing a gold
standard).
4.3.2 Well-characterized Mutations
Because HumDiv and HumVar are not considered LSDBs, we also assessed postMUT
on a set of mutations extracted from four LSDBs. We previously described this set
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Figure 4.2 : Sensitivity and specificity estimates of the in silico methods SIFT, Mu-
tationAssessor and PolyPhen-2 (estimated using the postMUT (simple) model (red),
the postMUT model (green) without a gold standard) compared to sensitivity and
specificity estimated using the gold standard (Using Variants Directly) which means
to use the known functional status for each variant (black) in (A) HumDiv and (B)
HumVar.
of mutations and refer to it as well-characterized mutations (Hicks et al. 2011).
The set of mutations referred to as the ‘Well-Characterized Data’ contains n =
52 neutral and n = 215 deleterious mutations from four LSDBs considering cancer
associated genes: BRCA1, MLH1, MSH2 and TP53. These mutations contain man-
ually curated mutations either using literature or curated locus specific databases
for four cancer associated genes. They were previously discussed in Hicks et al.
(2011) and Chapter 3 where we used them to compare the accuracy of several algo-
rithms and showed predictions of functionality depend on the algorithm and sequence
alignment employed. This data has also been used to compare the accuracy of new
83
algorithms which predict missense mutation functionality as an independent data set
[Acharya and Nagarajaram, 2012, Sim et al., 2012].
In this section, functional predictions for the Well-characterized data were ob-
tained using the pre-computed predictions of four in silico methods from dbNSFP
(SIFT, PolyPhen-2, LRT and Mutation Taster) and using predictions of four meth-
ods obtained directly from websites (SIFT, PolyPhen-2, Align-GVGD and Muta-
tionAssessor). Venn diagrams reporting the disjoint categories are not shown for
brevity, but there is a 66% agreement of predicted deleterious mutations between the
methods using the predictions from dbNSFP and 68.3% agreement between methods
obtained directly from websites. We note the functional predictions from PolyPhen-
2 and SIFT are not necessarily the same using predictions obtained from dbNSFP
compared to predictions obtained from their respective websites. The sensitivity and
specificity estimates of the four methods in dbNSFP (Table 4.4) and the four algo-
rithms previously reported in Hicks et al. (2011) (Table 4.5) are reported. In both
tables, our postMUT model closely estimates the sensitivity and specificity of the in
silico methods using sets of mutations extracted from LSDBs.
4.3.3 Matched Normal/Tumor Breast Cancer Sequencing Data
An interesting application of our postMUT models is to investigate the proportion
of deleterious mutations using mutations found only in the tumor sample (somatic
only) or only in the normal sample (germline only), we obtained missense mutations
from two matched normal/tumor breast cancer genomes which are publicly available
on the website of Complete Genomics.
We downloaded matched tumor and normal cell line sequence data for two individ-
uals with breast cancer from the Public Genome Data Repository [Drmanac et al., 2010]
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publicly available (http://www.completegenomics.com/public-data/) software version
2.0.0.32 and Sample IDs (ATCC Numbers): HCC1187 (CRL-2322), HCC1187 BL
(CRL-2323), HCC2218 (CRL-2343), NA12880 (CRL-2363). We filtered for missense
mutations with a high variant quality score (VQHigh) resulting in n = 9236 and
n = 7487 mutations in the HCC1187 (normal) and HCC1187 BL (tumor) samples
and n = 9149 and n = 8881 mutations in the HCC2218 (normal) and NA12880 (tu-
mor) samples, respectively. We compared the normal and tumor sets of mutations
to obtain mutations in germline only, somatic only or in both the normal and tu-
mor. Using the samples HCC1187 (normal) and HCC1187 BL (tumor), there were
n = 3780, 2031 and 5456 mutations in germline only, somatic only, in both nor-
mal and tumor as compared to using the samples HCC2218 (normal) and NA12880
(tumor) which contained n = 1467, 1199 and 7582 mutations in germline only, so-
matic only, in both normal and tumor. The functional predictions of the mutations
from the di↵erent sets of mutations from the three in silico methods SIFT, Muta-
tionAssessor and PolyPhen-2 were obtained directly from their respective websites.
The number of mutations with predictions from all three algorithms is reported in
Tables 4.6 and 4.7. Using the postMUT (simple) and postMUT models, sensitivity
and specificity estimates were calculated for each algorithm in addition to the overall
proportion of deleterious mutations. The 1000 Genomes (Feb 2012 release) minor
allele frequencies (MAFs) for each set of mutations were obtained from wANNOVAR
[Wang et al., 2010, Chang and Wang, 2012].
Using the postMUT (simple) model (Table 4.6) and postMUT model (Table 4.7),
we report an enrichment of deleterious mutations in the germline only and somatic
only set of mutations compared to the mutations both in the normal and tumor.
We calculate the Pearson correlation coe cient between the MAF reported in 1000
87
Genomes and the continuous score or probability reported by the in silico method
(SIFT, MutationAssessor, PolyPhen-2) compared to the posterior probability from
postMUT and show there is an increase in negative correlation in the germline only
and somatic only set of mutations compared to the mutations both in the normal
and tumor (Table 4.8). The germline only variants may refer to variants that are on
the allele which is lost during tumor development or may be variants where there is
not su cient coverage of the base in the tumor data. However, neither of these two
hypotheses is necessarily a unique explanation of why proportion of variants predicted
as deleterious would be higher in the germline only variants.
PolyPhen-2 is most correlated with MAF. We calculate the proportion of variants
predicted deleterious by each individual algorithm and by postMUT (i.e. at least 2
out of 3 algorithms predicted the mutations deleterious; see Section 4.3.4 for a further
discussion on the posterior probabilities) when considering MAF < 0.01 and MAF
  0.01 (Figure 4.3). In general, the proportion of variants predicted deleterious is
higher for the rare variants compared to the common variants. PolyPhen-2 has the
largest proportion of variants predicted deleterious when considering mutations in
both cases (MAF < 0.01 and MAF   0.01) compared to using the posterior probabil-
ities from postMUT which have a lower proportion of variants predicted deleterious
when considering both low-frequency and common variants (MAF   0.01).
4.3.4 Posterior Probabilities
These posterior probabilities introduced are a function of the estimated parameters
(overall proportion of deleterious mutations, sensitivity and specificity of each in silico
method) and the functional predictions reported by each in silico method. Consider
Table 4.2 which gives example labels for the 8 categories from the n = 3 methods.
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Figure 4.3 : The proportion of mutations predicted deleterious by the three in silico
methods (PolyPhen-2 (PPH2), SIFT, MutationAssessor (Xvar)) and by postMUT
(high posterior probability) considering set of mutations that are rare (MAF < 0.01)
or low-frequency and common (MAF   0.01) for individuals HCC1187 (A), (B) and
HCC2218 (C), (D).
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Figure 4.4 gives example posterior probabilities for these n = 3 methods when the
overall proportion of deleterious mutations is small (20%) and large (80%), respec-
tively. For each figure, we consider two models di↵ering if all the methods perform
similarly in accuracy or not. In Model A, 2 out of the 3 methods perform similarly
well, but the third performs worse resulting in posterior probabilities that weigh the
first two methods more heavily than the third algorithm. In Model B and all three
methods perform similarly well resulting in posterior probabilities with a wide gap
between Group 2 (only one method predicted the mutation deleterious) and Group 3
(at least two methods predicted the mutation deleterious). We also see the posterior
probabilities are heavily influenced by the overall proportion of deleterious mutations
as seen by the overall shift between Figure 4.4A and Figure 4.4B.
4.3.5 Identifying Functional Mutations inWhole-Exome Sequencing Data
We applied the postMUT models to unpublished real human exome sequencing data
obtained from a collaborator Sharon Plon, M.D., Ph.D., at Baylor College of Medicine
in Houston, Texas. This data was initially sequenced to identify cancer susceptibility
genes for acute lymphocytic leukemia (ALL) and lymphoma including probands with
childhood onset of leukemia and siblings (and more extended relatives) with ALL
or lymphoma. ALL is the most common pediatric cancer, but little is known about
the inherited predisposition to ALL. Figure 4.5 describes an extended pedigree with
four cases of lymphocytic leukemia and lymphoma for which samples and cell lines
are available on multiple family members. Whole exome sequencing analysis was
performed at the Human Genome Sequencing Center (HGSC) at Baylor College of
Medicine under the direction of David Wheeler, Ph.D. and Richard Gibbs, Ph.D.
Using the postMUT model, the overall proportion of deleterious mutations esti-
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Figure 4.4 : Example posterior probabilities as a function of sensitivity and specificity
of n = 3 in silico methods with 8 categories where the overall proportion of deleterious
mutations is p = 0.20 in (A) and p = 0.80 in (B). In Model A the first two methods
perform similarly well (a1 = 0.10, a2 = 0.15 and b1 = 0.90, b2 = 0.90), but the third
method performs worse (a3 = 0.30, b3 = 0.70) as opposed to Model B in which all
three methods perform similarly well (a1 = 0.10, a2 = 0.15, a3 = 0.10 and b1 = 0.90,
b2 = 0.90, b3 = 0.85). Considering Table 4.2, Group 1 represents category 1 (no algo-
rithms predicted the mutation deleterious), Group 2 represents categories 2-4 (only
one algorithm predicted the mutation deleterious), Group 3 represents categories 5-7
(at least two algorithms predicted the mutation deleterious) and Group 4 represents
category 8 (all three algorithms predicted the mutation deleterious)
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Figure 4.5 : Extended Pedigree with four cases of lymphocytic leukemia and lym-
phoma
mated for the a↵ected individuals (FCP416, FCP418, FCP502) and una↵ected indi-
vidual (FCP417) was 19.6%, 17.7%, 21.9% and 19.9%, respectively. Table 4.9 shows
the posterior probabilities for each variant being deleterious within the individual
showed if at least 2 out of 3 algorithms (SIFT, PolyPhen-2 and MutationAssessor)
predict the variant to be deleterious, then there is a high posterior probability of being
deleterious (> 80%). Because the sensitivity and specificity of the in silico methods
estimated in this application perform similarly, we use this as a cuto↵ to determine
which mutations are predicted deleterious by the postMUT models.
We applied a set of three filters to search for candidate mutations:
1. Mutations observed in three a↵ected individuals, but not in the una↵ected in-
dividual
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Table 4.9 : Example posterior probabilities of being deleterious given the ob-
served functional prediction from the three algorithms SIFT, MutationAssessor and
PolyPhen-2 for an a↵ected (FCP416) and una↵ected (FCP417) individual. N = neu-
tral prediction, D = deleterious prediction.
SIFT MutationAssessor PolyPhen-2 Posterior (a↵ected) Posterior (una↵ected)
D D D 0.932 0.887
N D D 0.858 0.836
D N D 0.865 0.832
D D N 0.845 0.826
D N N 0.194 0.211
N D N 0.180 0.220
N N D 0.218 0.234
N N N 0.035 0.048
2. Low minor allele frequency: < 1%
3. High posterior probability from the postMUT model: cuto↵ > 80%
Using these three filters, we identified a set of 80 candidate missense mutations to
be further analyzed using biological functional assays.
4.4 Discussion
Interpreting the functional impact of missense mutations on protein function is an
important step in identifying disease-causing mutations. Even though the majority
of in silico methods predicting the functionality of missense mutations utilize similar
information in the form of evolutionary conservation (specifically phylogenetic infor-
mation) to assess the e↵ect of the mutation on protein function [Jordan et al., 2010],
they often lead to conflicting results leaving the user without guidance in assessing
the pathogenic impact of missense mutations on protein function. Two recent reviews
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[Sifrim et al., 2012, Lyon and Wang, 2012] comparing the features and limitations of
these methods concluded first-principles methods (and especially genomic annotation
tools) often have disagreeing and constantly evolving annotations leading to di↵erent
sets of final candidate variants when employing di↵erent in silico methods.
There are many other technical problems related to using these first-principles and
trained classifiers in silico methods. For example, most sets of mutations with known
functionality (gold standards) used to calibrate or train the classifiers are only weakly
associated with disease. Many web-based algorithms do not allow the user to submit
a large number of mutations, but some may allow the user to download and maintain
an in-house version of the algorithm leading to questions of reproducibility. Wong et
al. (2011) discussed the problem of di↵erent methods requiring di↵erent input and
output formats. One way to avoid this problem is to employ databases containing pre-
computed predictions of functionality such as dbNSFP [Liu et al., 2011] or SNVBox
[Wong et al., 2011], but the pre-computed predictions between di↵erent versions of
the databases may vary greatly and often the missense mutations are missing from
the database entirely depending on the gene list used to create the database. Further
research is needed to address these technical di culties.
These posterior probabilities produced by our postMUT models combine discor-
dant functional predictions from the individual in silico methods in the absence of a
gold standard by taking advantage of the fact that these methods disagree. Though
the parameter estimates from the two postMUT models converge to estimates sim-
ilar to estimates using a gold standard, issues may exist with identifiability of the
parameters when performing estimation. These problems are recognized in a more
general context of mixture models [McLachlan and Peel, 2000]. Parameters of our
models are estimated using the EM algorithm which iteratively finds the maximum
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likelihood when there is latent or missing data involved. Potential problems with the
identifiability of parameters when performing estimation are addressed by imposing
intuitive identifiability constraints in the parameter space as suggested by McLachlan
and Peel (2000). Specifically, we require the false positive rate = aj < 0.50 and true
positive rate = bj > 0.50 to prevent the algorithm from yielding predictions worse
than fair coin flipping.
Recently, several groups have taken a more comprehensive approach developing
annotation and prioritization tools. Functional annotation tools are the third group
of in silico methods with the goal to infer the functionality of missense mutations by
annotating batch sets of mutations from whole-exome or whole-genome data. These
are often open-access tools or webservers which report predictions of functionality
from di↵erent algorithms and annotations from large databases without any formal
interpretation of functionality. Conversely, disease gene prioritization tools try to
infer candidate disease genes. These tools include some functional annotations, but
they are mostly focused on automating the filtering process when searching for disease
causal genes. Lyon and Wang (2012) describe two approaches on inferring candidate
genes from whole-exome or whole-genome sequencing data:
1. A probabilistic scoring approach (conceptually more sophisticated and less likely
to miss causal genes) combining multiple sources of data into a statistical model
which ranks the genes by their probability of being disease-causing
2. A stepwise reduction approach (also referred to as intersection filtering
[Robinson et al., 2011]) which is more easily interpreted removing variants based
on filters such as allele frequency, segregation with disease and functional pre-
dictions to end up at a list of candidate genes
98
Some examples of probabilistic scoring disease gene prioritization tools have been
developed such as VAAST [Yandell et al., 2011] or KGGSeq [Li et al., 2012], but
these tools do not have the same goal as the in silico methods inferring the func-
tionality of missense mutations and therefore are not directly comparable. Rather,
we argue the posterior probability of pathogenicity used to infer the functionality of
missense mutations introduced in this chapter may be incorporated into tools such
as in disease gene prioritization tools.
In this chapter, we developed a method to combine these discordant functional
predictions and to provide a unifying probability of pathogenicity for each missense
mutation which may be used to prioritize the mutations identified for further evalua-
tion in biological laboratory-based assays. As the interpretation of missense mutations
still remains an elusive and di cult task, we provide a novel, scalable tool to infer the
functionality of missense mutations which is an important step in assessing causality
and identifying disease susceptibility mutations.
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Chapter 5
Simulation Studies to Evaluate the Performance of
postMUT Models
In this chapter, we investigate the performance of the postMUT (simple) and post-
MUT models by performing simulation studies. We simulate predictions of function-
ality for m mutations from n in silico algorithms using either the postMUT (simple)
model (Section 5.1) and the postMUT model (Section 5.2) with known parameters ✓.
After the obtaining the simulated functional predictions, X, we perform parameter
estimation using both postMUT models to obtain ✓ˆ. We assess bias and root mean
squared error (RMSE) of the parameters as a function of the number of mutations
m. Bias is defined as
Bias(✓ˆ) = E[✓ˆ   ✓] (5.1)
and the estimator is said to be unbiased if the bias is equal to zero. MSE is defined
as
MSE(✓ˆ) = E[(✓ˆ   ✓)2] = V ar(✓ˆ) + [Bias(✓ˆ)]2 (5.2)
which assess the quality of the estimator in terms of its variance and degree of bias
[Shao, 2003].
In both Section 5.1 and 5.2, we asked the following three questions:
1. How do bias and RMSE vary as a function of the overall proportion of deleterious
mutations p? (Simulation Study 1)
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2. How do bias and RMSE vary as the sensitivity and specificity of in silico algo-
rithms changes? (Simulation Study 2)
3. How do bias and RMSE vary as the number of in silico algorithms increases?
(Simulation Study 3)
5.1 Performance on Simulated Data using the postMUT (sim-
ple) Model
Using functional predictions simulated from the postMUT (simple) model, we con-
sider three di↵erent simulation studies which are described in Table 5.1. We explore
di↵erent ranges of the parameters. Parameter estimation is performed using the
postMUT (simple) and postMPUT models.
5.1.1 Simulation Study 1: Varying p
As a function of the overall proportion of deleterious mutations p, we consider p =
0.05, 0.20, 0.80 to explore the range of p 2 [0, 1]. When p is small (p = 0.05 or 0.20),
the RMSE(aj) < RMSE(bj) 8 j because the majority of the variants in this set are
neutral. When using a set of mostly deleterious variants (p = 0.80), the RMSE(aj)
> RMSE(bj) 8 j because the majority of the variants are deleterious (Figures 5.1,
5.2). Figure 5.3 shows example asymptotic Wald confidence regions for increasing
false positive rates (a1 = 0.10 < a2 = 0.20 < a3 = 0.30) and decreasing true positive
rates are decreasing (b1 = 0.10 > b2 = 0.20 > b3 = 0.30) when considering a small
proportion of variants, p = 0.20 and large proportion of variants, p = 0.80 with n =
3 algorithms and m = 2000 mutations. The confidence regions using p = 0.20 are
ellipsoids growing larger along the y-axis as sensitivity (true positive rate) decreases
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because the majority of the mutations are neutral and therefore less information is
available to estimate the sensitivity. Similarly, using p = 0.80, the ellipsoid confidence
regions grow larger along the x-axis as 1 - specificity (false positive rate) grows larger
because most of the mutations are deleterious. We note the confidence regions are
also a function of the number of mutations: as the number of mutations increase, the
confidence regions decrease. Additionally, when p is small pˆ is negatively biased, but
positively biased when pˆ is large (Figure 5.1) when estimating with the postMUT
model.
5.1.2 Simulation Study 2: Varying aj, bj
Next, we compare models which vary aj and bj. As we increase the false positive rate
and decrease the true positive rate (Model A, Model 2.1, Model 2.2, Model 2.3 in
Table 5.1), we see the bias and RMSE increases (Figures 5.4, 5.5). Surprisingly, when
comparing Model A to Model 2.1 we see the MSE(a1) = RMSE(a2) > RMSE(a3) and
RMSE(b1) = RMSE(b2) > RMSE(b3) even though the sensitivity and specificity of
algorithms 1 and 2 are better than algorithm 3. This seems to stem from the nature
of the disjoint categories. When the algorithms perform equally well in sensitivity
and specificity (Model A), the algorithms disagree equally. When the algorithms do
not perform equally well (Model 2.1), the algorithms do not disagree equally forcing
some categories to be weighed more heavily (Figure 5.6) influencing the accuracy of
the postMUT models.
5.1.3 Simulation Study 3: Varying n
As the number of algorithms increases, the number of parameters to estimates in-
creases in both the postMUT (simple) model (2n + 1) and the postMUT model (2n
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Figure 5.3 : Examples of 95% Wald confidence regions of sensitivity and specificity
parameter estimates using postMUT (simple) model considering n = 3 simulated in
silico algorithms, m = 2000 mutations and p = 0.20 (left), p = 0.80 (right). For
each of the n = 3 algorithms, mutations were simulated with increasing false positive
rates (a1 = 0.10 < a2 = 0.20 < a3 = 0.30) and decreasing true positive rates
(b1 = 0.90 > b2 = 0.80 > b3 = 0.70).
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Figure 5.6 : Venn diagrams comparing the proportion of mutations (m = 2000)
simulated from the postMUT (simple) model when n = 3 in silico algorithms perform
equally well in sensitivity and specificity (Model A in Table 2, left Venn diagram) and
when the in silico algorithms do not perform equally well (Model 2.1 in Table 2, right
Venn diagram).
+ 3). Even with more parameters to estimate, the overall RMSE decreases when n =
4 than compared to n = 3 in both the cases p = 0.20 and p = 0.80 (Figures 5.7, 5.8).
This indicates it is advantageous to use functional predictions from more algorithms.
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5.2 Performance on Simulated Data using the postMUTModel
Next, we simulate functional predictions using the postMUT model. Again, we con-
sider three di↵erent simulation studies which are described in Table 5.2. We explore
di↵erent ranges of the parameters similar to Section 5.1. We calculate dj, ej listed
in Table 5.2 using the marginal probabilities in equations 4.4, so they match aj and
bj in Table 5.1. Parameter estimation is performed using the postMUT (simple) and
postMPUT models.
5.2.1 Simulation Study 1: Varying p
As we vary p, the bias and RMSE of dj, ej are very small when estimating the
parameters using the postMUT model, but the bias and RMSE of aj, bj are much
larger when estimating with the postMUT (simple) model and postMUT model. This
is because the bias and RMSE of   and   are large (Figures 5.9, 5.10). Additionally,
when p is small, pˆ is positively biased, but negatively biased when p is large (Figure
5.9) when estimating with the postMUT (simple) and postMUT models.
5.2.2 Simulation Study 2: Varying aj, bj
Next, we compare bias and RMSE of algorithms with increasing in false positive
rates and decreasing true positive rates (Models A, 2.1, 2.2 and 2.3). Similar to the
results seen in Section 5.1, the RMSE(a1) = RMSE(a2) > RMSE(a3) and RMSE(b1)
= RMSE(b2) > RMSE(b3) even though the sensitivity and specificity of algorithms 1
and 2 are better than algorithm 3 (Figures 5.11, 5.12). Again, this e↵ect is not due
to the model, but rather from the agreement seen in the disjoint categories (Figure
5.6).
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5.2.3 Simulation Study 3: Varying n
When estimating using the postMUTmodel, the bias and RMSE of dj and ej decreases
as the number of algorithms n increases. As noted in Simulation Study 1 because
the bias and RMSE of   and   are large, we do not see a reduction in bias or RMSE
when we calculate the marginal probabilities aj and bj (Figures 5.13, 5.14).
5.3 Discussion
In this chapter, we investigated the performance of the postMUT (simple) and post-
MUT models using simulation studies. We assessed the bias and RMSE for a statis-
tical model we developed Chapter 4 based on the capture-recapture paradigm. These
models combine discrete discordant functional predictions (neutral or deleterious) in
a statistically rigorous manner and estimate a unified posterior probability for each
mutation being deleterious. In absence of a gold standard (or set of mutations with
known functionality), the models jointly estimate the sensitivities (probability of cor-
rectly predicting a deleterious mutation) and specificities (probability of correctly
predicting a neutral mutation) of each in silico method and the overall proportion of
deleterious mutations in the dataset using the Expectation-Maximization algorithm.
We previously gave examples Chapter 4 of how the two postMUT models perform
on real sets of missense mutations with and without a ‘gold standard’ (mutations with
known functionality). Even with assumptions of conditional independence between
the algorithms, we showed the sensitivity and specificity estimates using the postMUT
models closely match the sensitivity and specificity estimated directly using the known
functional mutation status. We also discussed technical issues with the identifiability
of the parameters when performing parameter estimation. These problems are well-
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recognized in a more general context of mixture models (McLahlan and Peel, 2000).
A perfect algorithm would report bj = 1 and aj = 0, but in reality the true positive
rate and false positive rate may each range from [0,1]. Therefore, we impose two
identifiability constraints aj 2 [0, 0.50] and bj 2 [0.5, 1] when performing parameter
estimation. If the parameters were outside this range, the algorithm would have worse
accuracy than randomly flipping a coin. After performing the simulation studies, we
feel improvements still need to be made to the postMUT model because we see the
large bias and RMSE for the   and   parameters. One possible way to improve our
model could be to incorporate additional information such as the continuous score or
probability of a mutation being predicted deleterious (or neutral) produced from these
algorithms to more accurately determine the true functionality of missense mutations.
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Chapter 6
Identifying Regions of Identity-by-Descent
In this chapter, we develop several hidden Markov models (HMMs) to identify regions
of identity-by-descent (IBD) (or chromosomal segments in related individuals inher-
ited from the same haplotype from each parent) using the observed identity-by-state
(IBS) status from whole-exome sequencing data. These HMMs use the IBS status
which describes the number of shared alleles between two a↵ected siblings. In consan-
guineous families, the shared alleles will be homozygous, but in non-consanguineous
families, the shared alleles may be heterozygous, but identically shared in each sibling.
We consider several extensions of a previously developed first-order HMM
[Ro¨delsperger et al., 2011] by exploring conditional emission probabilities and also
a second-order dependence structure between the observed variant calls in siblings.
Due to the structure of the conditional emission probabilities we derive a a Viterbi-
type algorithm to predict regions of IBD. These models are inhomogeneous because
the transition probabilities at each position vary depending on the position and sex-
specific recombination rates. In addition, we show the emission probabilities used
in the HMMs are a function of the minor allele frequency suggesting minor allele
frequency should be used in determining IBD regions using whole-exome sequencing
data.
In Section 6.1, we discuss the whole-exome sequencing data used in this chapter.
Section 6.1.1 describes the procedure for simulating whole-exome data and Section
6.1.2 introduces a set of whole-exome sequencing data from a family a↵ected by acute
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lymphocytic leukemia and lymphoma. Table 6.1 describes five HMMs which we refer
to as the Rodelsperger et al. (2011) Model, Model A (Section 6.3), Model B (Section
6.4), Models C and D (Section 6.5). In Section 6.3, we derive a first-order HMM
with conditional emission probabilities which depend not only on the IBD status,
but also the IBS status at the previous position. In this section, we treat IBD as
a binary status of either IBD 6= 2 or IBD = 2. In Section 6.4, we derive a second-
order HMM with second-order transition probabilities and and emission probabilities.
Then in Section 6.5, we re-define the IBD and IBS status as {0, 1, 2} (representing
the number of alleles shared between pairs of individuals) and use a first-order HMM
with conditional emissions.
We compare the results from the HMMs using simulated exome sequencing data
and real exome sequencing data from two a↵ected siblings in an autosomal dominant
family discussed in Section 6.1.2 as an analysis in Section 6.7.
6.1 Exome Data
6.1.1 Simulated Exome Data
Following Rodelsperger et al. (2011), I simulated N = 1000 families with n = 2
siblings. First, I downloaded the genotypes of trios from Hapmap (Phase 3, hg18)
[International HapMap Consortium, 2003] and extracted all female and male founders
from the population. Parents were randomly sampled (1 maternal and 1 paternal) by
sampling diploid chromosomes from individuals. To simulate the o↵spring, I generate
1 recombinant gamete from a female and 1 recombinant gamete from a male to make
1 o↵spring (repeat this process for n siblings). Next, a subset of the genotypes
are kept by only using the positions in the CCDS coordinates [Pruitt et al., 2009].
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For each sibling, I simulated genotype calling errors with probability ✏ = 0.05 and
sequencing false-positive calls with probability   = 0.001. Finally, positions were
eliminated where there were no variant calls in n siblings. If there was at least one
variant observed in one of the siblings, then the IBD and IBS status of this variant
was recorded. For families with two siblings the expected proportion of the genome
that is IBD = 2 is 14 . Figure 6.1 shows the proportion of simulated genomes that are
IBD = 2 matches the expected number.
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Figure 6.1 : Proportion of simulated exomes that are IBD=2.
124
6.1.2 Whole-Exome Sequencing Data
In addition to simulated whole-exome sequencing data, we use the unpublished real
human exome sequencing data discussed in Section 4.3.5. The whole exome sequenc-
ing data from two siblings (FCP502 and FCP416) were used in this analysis. We note
that this family does not follow a recessive inheritance pattern which is the inheri-
tance pattern that the HMM in this thesis was developed for. This family with an
autosomal dominant inheritance pattern is used as just an example.
Figure 6.2 : Extended Pedigree with four cases of lymphocytic leukemia and lym-
phoma. Same pedigree considered as in Section 4.3.5.
6.2 Inhomogeneous HMMs for predicting regions of IBD
In this section, several extensions of a first-order HMM [Ro¨delsperger et al., 2011]
previously developed are considered. The models considered in this chapter are listed
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in in Table 6.1.
The first-order HMM developed by Rodelsperger et al. (2011) is listed first. Model
A is defined as 1st-order HMM, but with conditional emission probabilities, P [Xn =
b|Xn 1 = c, ⇡n = i]. These emission probabilities depend not only on the unobserved
IBD status at position n, but also the observed IBS status at position n   1. We
define a new Viterbi-type algorithm to predict regions of IBD with these conditional
emission probabilities. Model B extends the first-order HMM to a second-order HMM
by investigating the second-order dependence structure between the observed variant
calls in siblings. The emission probabilities are also second-order, P [Xn = b|⇡n =
j, ⇡n 1 = i]. Model C redefines the IBD status from IBD = 2 or IBD 6= 2 to IBD
= 0, 1, 2. It also redefines the IBS status to IBS = 0, 1, 2 (i.e. number of shared
alleles between two a↵ected siblings). Model D is estimated using Model C, but after
obtaining the predicted IBD regions 2 {0, 1, 2} we convert the IBD status to IBD = 2,
IBD 6= 2 to compare to first three models. Finally, we consider emission probabilities
as a function of minor allele frequency.
6.3 Model A
In this section we consider a first-order inhomogenous HMM but with conditional
emission probabilities. Let ⇡n be a first-order inhomogeneous Markov process where
⇡n =
8><>: 1 if position n is IBD = 2 in two siblings0 otherwise
The IBD status ⇡n is not observable, but we do observe the IBS status Xn
Xn =
8><>: 1 if position n is IBS
⇤ in two siblings
0 otherwise
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where IBS⇤ is defined as each sibling being called to the same homozygous or het-
erozygous genotype.
6.3.1 First-order Transition Probabilities
The probability that position n is IBD = 2 in two siblings is
P1 = P [⇡n = 1] = (
1
4
)2
and the probability that position n is IBD 6= 2 is
P0 = P [⇡n = 0] = 1  (1
4
)2
For any two loci (n and n+ 1), the first-order inhomogeneous Markov chain is char-
acterized by the transition probability matrix
Pij = P [⇡n+1 = j|⇡n = i]
where the transition probabilities depend on the sex-specific recombination rates be-
tween n and n + 1 loci positions for the gender s. The recombination rates are
defined as ✓n,n+1,s. These rates can be easily obtained from the UCSC Browser with
the rtracklayer R package [Lawrence et al., 2009].
To compute these transition probabilities, the conditional probability that given
loci n is IBD = 2, the probability that loci n + 1 is IBD = 2 in two siblings is given
by
P11 = [(1  ✓n,n+1,p)2 + (✓n,n+1,p)2][(1  ✓n,n+1,m)2 + (✓n,n+1,m)2]
Then the joint probability that a pair of adjoining loci (n, n+ 1) are both IBD = 2:
P [⇡n = 1, ⇡n+1 = 1] = P [⇡n+1 = 1|⇡n = 1]P [⇡n = 1] = P11P1
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This leads to the following conditional and joint probabilities:
P01 = P [⇡n+1 = 1|⇡n = 0] = P [⇡n = 0|⇡n+1 = 1]P [⇡n+1 = 1]
P [⇡n = 0]
=
(1  P [⇡n = 1|⇡n+1 = 1])P [⇡n+1 = 1]
P [⇡n = 0]
=
(1  P [⇡n=1,⇡n+1=1]P [⇡n+1=1] )P [⇡n+1 = 1]
P [⇡n = 0]
=
P [⇡n+1 = 1]  P [⇡n = 1, ⇡n+1 = 1]
P [⇡n = 0]
=
P1   P11
P0
P10 = 1  P11
P00 = 1  P01
6.3.2 First-order Conditional Emissions
The conditional emission probabilities are given by
e(Xn 1,⇡n)(Xn) = P [Xn|Xn 1, ⇡n]
We estimate the conditional emission probabilities two ways: 1) using the empirical
frequency estimates from the simulated families (Section 6.1.1) and 2) simulating 3-
loci and estimating the conditional emissions as a function of minor allele frequency.
Several groups using SNP array data have used minor allele frequencies and haplo-
type frequencies as a way to estimate emission probabilities [Albrechtsen et al., 2009,
Han and Abney, 2011], but have not tried to assess their influence using whole-exome
sequencing data. To do this, we simulated data with three points representing the
three loci n  2, n  1, and n in the following procedure:
1. Repeat the following 10 times:
(a) Repeat the following 1,000,000 times:
129
i. For 3 positions, define MAFs for position n 1 and n: p(a), p(b), p(c).
Compute genotype probabilities: p(AA), p(Aa), p(aa), p(BB), p(Bb),
p(bb), p(CC), p(Cc), p(cc).
ii. Simulate mother and father genotypes at 3 positions. Convert to hap-
lotypes.
iii. Simulate maternal and paternal haplotypes for each sibling using de-
fined recombination frequency between position n   2 and n   1 and
recombination frequency between position n 1 and n. Simulate geno-
typing error with probability ✏ = 0.05. Determine IBS and IBD status.
iv. Record what event was simulated (e.g. Xn = 1, ⇡n = 2)
(b) Calculate emission probabilities:
i. Rodelsperger 1st-order emissions: P [Xn = 1|⇡n = 1]
ii. 1st-order conditional emissions: P [Xn = 1|Xn 1, ⇡n = 1]
2. Calculate mean and standard deviation of emission probabilities
We used the 1000 Genomes minor allele frequencies (Feb 2012 release) for each set of
mutations using wANNOVAR [Wang et al., 2010, Chang and Wang, 2012]
As show in Figure 6.3.2, the emission probabilities conditional on IBD 6= 2 at
position n from the Rodelsperger et al. (2011) Model vary as function of minor allele
frequency. Figure 6.3.2 shows the emission probabilities in Model A also vary as a
function of minor allele frequency.
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Figure 6.3 : Emission probabilities in Rodelsperger et al. (2011) model as a function
of MAF
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Figure 6.4 : Emission probabilities in Model A as a function of MAF
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6.3.3 New Joint Distribution (X, ⇡)
Because the emissions are conditional on both the IBD and IBS status, we derived
the new joint distribution of (X, ⇡). Consider
En = P [X1, . . . , Xn|⇡1, . . . , ⇡n]
= P [Xn|X1, . . . , Xn 1, ⇡1, . . . , ⇡n]P [X1, . . . , Xn 1|⇡1, . . . , ⇡n]
= P [Xn|Xn 1, ⇡n]En 1
This leads to the following relationship for the entire sequence of length L
EL = P [X|⇡] = E1
LY
n=1
P [Xn|Xn 1, ⇡n]
Next, consider the joint distribution of ⇡ up until the nth position
⇧n = P [⇡1, . . . , ⇡n]
= P [⇡n|⇡1, . . . , ⇡n 1]P [⇡1, . . . , ⇡n 1]
= P [⇡n|⇡n 1]⇧n 1
Then,
⇧L = P [⇡] = ⇧1
LY
n=1
P [⇡n|⇡n 1]
Then, the joint distribution of X and ⇡ is given by
P (X, ⇡) = P [X|⇡]P [⇡] = EL⇧L
= E1⇧1
LY
n=1
P [Xn|Xn 1, ⇡n]P [⇡n|⇡n 1]
= E1⇧1
LY
n=1
e(Xn 1,⇡n)(Xn)P⇡n,⇡n 1
where e(Xn 1,⇡n)(Xn) is a conditional emission probability for the nth position and
P⇡n,⇡n 1 is the transition probability at the nth step given the previous step.
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6.3.4 New Iterative Viterbi-type Algorithm
To make inference on the hidden path ⇡, we may define a Viterbi-type algorithm that
incorporates the new conditional emission probabilities. We use an iterative For-
ward Algorithm that maximizes the likelihood P (X, ⇡) with respect to the unknown
parameters ✓ = (e, P ). Consider
max
⇡
P (X, ⇡) = max
⇡1,...,⇡L
E1⇧1
LY
n=1
P [Xn|Xn 1, ⇡n]P [⇡n|⇡n 1]
= max
⇡1,...,⇡L
P [XL|XL 1, ⇡L]P [⇡L|⇡L 1]⇥ P [XL 1|XL 2, ⇡L 1]P [⇡L 1|⇡L 2]⇥ . . .
. . .⇥ P [X3|X2, ⇡3]P [⇡3|⇡2]⇥ P [X2|X1, ⇡2]P [⇡2|⇡1]⇥ P [X1|⇡1]P [⇡1|⇡0]P [⇡0]
= max
⇡L
{ P [XL|XL 1, ⇡L] max
⇡1,...,⇡L 1
{ P [⇡L|⇡L 1]⇥ P [XL 1|XL 2, ⇡L 1]
⇥ P [⇡L 1|⇡L 2]⇥ . . .⇥ P [X2|X1, ⇡2]P [⇡2|⇡1]⇥ P [X1|⇡1]P [⇡1|⇡0]P [⇡0] } . . .}
= max
⇡L
{ P [XL|XL 1, ⇡L] max
⇡L 1
{ P [⇡L|⇡L 1]⇥ P [XL 1|XL 2, ⇡L 1]
max
⇡L 2
{ P [⇡L 1|⇡L 2]⇥ . . .⇥ P [X4|X3, ⇡4] max
⇡3
{ P [⇡4|⇡3]⇥
⇥ P [X3|X2, ⇡3] max
⇡2
{ P [⇡3|⇡2]⇥ P [X2|X1, ⇡2]
max
⇡1
{ P [⇡2|⇡1]⇥ P [X1|⇡1] max
⇡0
{ P [⇡1|⇡0]⇥ P [⇡0] } . . .}
Implementing New Iterative Viterbi-type Algorithm
The inhomogeneous transition probabilities and emission probabilities for Model A
discussed in this section were programmed in R. We implemented the iterative Viterbi-
type algorithm to calculate the path or predict the IBD states.
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6.4 Model B
In this section, we extend the first-order inhomogenous HMM [Ro¨delsperger et al., 2011]
to a second-order HMM to investigate the second-order dependence structure between
the observed variant calls in siblings. Let ⇡n be a second-order inhomogeneous Markov
process where
⇡n =
8><>: 1 if position n is IBD = 2 in two siblings0 otherwise
The IBD status ⇡n is not observable, but we do observe the IBS status Xn
Xn =
8><>: 1 if position n is IBS
⇤ in two siblings
0 otherwise
where IBS⇤ is defined as each sibling being called to the same homozygous or het-
erozygous genotype.
6.4.1 Second-order Transition Probabilities
In Section 6.3.1, we described the first-order transition probabilities using any two
loci( n, n + 1). For any three loci (n  1, n, n+ 1), the second-order inhomogeneous
Markov process is characterized the transition probability matrix
Pijk = P [⇡n+1 = k|⇡n = j, ⇡n 1 = i]
The second-order transition probabilities depend on the sex-specific recombination
rates between the n   1 and n loci positions and between the n and n + 1 loci
positions for the gender s. The recombination rates are defined as
✓n 1,n,s = ✓(n  1, n, s) and ✓n,n+1,s = ✓(n, n+ 1, s)
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These rates can be easily obtained from the UCSC Browser with the rtracklayer R
package [Lawrence et al., 2009].
Using these recombination rates, we derive the second-order transition probabili-
ties. The conditional probability that given loci n 1 and n is IBD = 2, the probability
that loci n+ 1 is IBD = 2 in two siblings is given by
P111 =
P [⇡n+1 = 1, ⇡n = 1, ⇡n 1 = 1]
P [⇡n = 1, ⇡n 1 = 1]
which equals
{ [((1  ✓n 1,n,p)(1  ✓n,n+1,p))2 + ((✓n 1,n,p)(1  ✓n,n+1,p))2 + ((1  ✓n 1,n,p)(✓n,n+1,p))2 + ((✓n 1,n,p)(✓n,n+1,p))2]
⇥ [((1  ✓n 1,n,m)(1  ✓n,n+1,m))2 + ((✓n 1,n,m)(1  ✓n,n+1,m))2 + ((1  ✓n 1,n,m)(✓n,n+1,m))2 + ((✓n 1,n,m)(✓n,n+1,m))2]
⇥ P1 }/P [⇡n = 1,⇡n 1 = 1]
Then the joint distribution for the three loci (n  1, n, n+ 1) being IBD = 2 is
P [⇡n+1 = 1, ⇡n = 1, ⇡n 1 = 1] = P111P11
Similarly,
P011 = P [⇡n+1 = 1|⇡n = 1, ⇡n 1 = 0]
=
P [⇡n 1 = 0|⇡n = 1, ⇡n+1 = 1]P [⇡n+1 = 1, ⇡n = 1]
P [⇡n = 1, ⇡n 1 = 0]
=
(1  P [⇡n 1 = 1|⇡n = 1, ⇡n+1 = 1])P [⇡n+1 = 1, ⇡n = 1]
P [⇡n = 1, ⇡n 1 = 0]
=
(1  P [⇡n+1=1,⇡n=1,⇡n 1=1]P [⇡n+1=1,⇡n=1] )P [⇡n+1 = 1, ⇡n = 1]
P [⇡n = 1, ⇡n 1 = 0]
=
P [⇡n = 1, ⇡n+1 = 1]  P [⇡n 1 = 1, ⇡n = 1, ⇡n+1 = 1]
P [⇡n = 0, ⇡n 1 = 0]
=
P11   P111
P00
P110 = 1  P111
P010 = 1  P011
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and
P [⇡n+1 = 1, ⇡n = 1, ⇡n 1 = 0] = P011P01
P [⇡n+1 = 0, ⇡n = 1, ⇡n 1 = 1] = P110P11
P [⇡n+1 = 0, ⇡n = 1, ⇡n 1 = 0] = P010P01
These conditional and joint probabilities are only for half of the transition probability
matrix. To fill in the other half, we consider the following scenario. Consider two
siblings and P101 be the probability that both siblings are IBD = 2 at loci n  1 and
n+ 1, but not at loci n. The only way for this to occur is if one of the siblings had a
recombination between loci (n 1, n) and (n, n+1). Thus, if we consider two siblings
then P101 translates to one sibling (but not both) had a recombination between [loci
(n  1, n) and (n, n+ 1). Hence, we define P101 as
[[✓n 1,n,p✓n,n+1,p]{[(1  ✓n 1,n,p)(1  ✓n,n+1,p)] + [✓n 1,n,p(1  ✓n,n+1,p)] + [(1  ✓1,2,p)✓2,3,p]}]
⇥ [[✓n 1,n,m✓n,n+1,m]{[(1  ✓n 1,n,m)(1  ✓n,n+1,m)] + [✓n 1,n,m(1  ✓n,n+1,m)] + [(1  ✓n 1,n,m)✓n,n+1,m]}]
Thus, the joint distribution is given by
P [⇡n+1 = 1, ⇡n = 0, ⇡n 1 = 1] = P101P10
Similarly,
P001 =
P [⇡n 1 = 0|⇡n = 0, ⇡n+1 = 1]P [⇡n = 0, ⇡n+1 = 1]
P [⇡n = 0, ⇡n 1 = 0]
=
(1  P [⇡n 1=1,⇡n=0,⇡n+1=1]P [⇡n=0,⇡n+1=1] )P [⇡n = 0, ⇡n+1 = 1]
P [⇡n = 0, ⇡n 1 = 0]
=
P01   P101
P00
P100 = 1  P101
P000 = 1  P001
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and
P [⇡n+1 = 1, ⇡n = 0, ⇡n 1 = 0] = P001P00
P [⇡n+1 = 0, ⇡n = 1, ⇡n 1 = 0] = P010P01
P [⇡n+1 = 0, ⇡n = 0, ⇡n 1 = 0] = P000P00
6.4.2 Second-order Emission Probabilities
Our second-order extension of Rodelsperger et al. (2011) emissions probabilities are
given by
eij(b) = P [Xn = b|⇡n = j, ⇡n 1 = i]
To estimate these emission probabilities, we used the same procedure as in Section
6.3.2. The emission probabilities which were estimated using the empirical frequencies
using the simulated families were programmed. In addition, the emission probabilities
estimated as a function of MAF at loci n  2, n  1 and n were also considered. As
show in Figure 6.4.2, the emission probabilities conditional on IBD 6= 2 at position n
from Model B vary as function of minor allele frequency.
6.4.3 Second-order Viterbi Algorithm
The inhomogeneous transition probabilities and emission probabilities discussed in
this section were programmed in R. We used the 1000 Genomes minor allele frequen-
cies (Feb 2012 release) for each set of mutations using wANNOVAR [Wang et al., 2010,
Chang and Wang, 2012] for the emission probabilities. A second-order Viterbi algo-
rithm [Thede and Harper, 1999] was employed to predict the loci IBD = 2 or IBD 6=
2. A marginal posterior probability of being in the IBD = 2 state was also estimated.
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Figure 6.5 : Emission probabilities in Model B as a function of MAF
6.5 Models C and D
For this last model, we considered an inhomogenous first-order HMM as in Section
6.3 (Model A), but we redefine the IBD status as an ordinal variable 2 {0, 1, 2} where
the status represents the number of alleles shared IBD between pairs of individuals.
We also redefined the IBS status 2 {0, 1, 2}.
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Let ⇡n by a first-order inhomogeneous Markov process where
⇡n =
8>>>><>>>>:
2 if position n is IBD = 2 in two siblings
1 if position n is IBD = 1 in two siblings
0 if position n is IBD = 0 in two siblings
IBD status ⇡n is not observable, but we do observe the IBS status Xn
Xn =
8>>>><>>>>:
2 if position n is IBS = 2 in two siblings
1 if position n is IBS = 1 in two siblings
0 if position n is IBS = 0 in two siblings
where the describes the number of shared alleles between two a↵ected siblings. In con-
sanguineous families, the shared alleles will be homozygous, but in non-consanguineous
families, the shared alleles may be heterozygous, but identically shared in each sibling.
6.5.1 First-order Transition Probabilities using IBD = 0, 1, 2
Consider two siblings. A locus n can be ⇡n = 0, ⇡n = 1 and ⇡n = 2 with probabilities
P [⇡n = 0] =
1
4
P [⇡n = 1] =
1
2
P [⇡n = 2] =
1
4
Using  m and  p which are functions of the sex-specific recombination rates (✓m,✓p):
 m = ✓
2
m + (1  ✓m)2
 p = ✓
2
p + (1  ✓p)2
we can compute the transition probabilities P [⇡n = j|⇡n 1 = i] between loci n and
n  1 using  m and  p. The transition probabilities are given in Table 6.2.
The joint probabilities are given by
P [⇡n = j, ⇡n 1 = i] = P [⇡n = j|⇡n 1 = i]P [⇡n 1 = i]
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6.5.2 First-order Conditional Emissions using IBD = 0, 1, 2
First-order conditional emission probabilities are given by
e(Xn 1,⇡n)(Xn) = P [Xn|Xn 1, ⇡n]
To estimate these emission probabilities, we used the same procedure as in Section
6.3.2. The emission probabilities conditional on IBD 6= 2 in Models C and D also
varied as a function of minor allele frequency at position n. There were 27 emission
probabilities in this HMM and did provide the plots for brevity.
6.6 Application to simulated exome sequencing data
6.6.1 Simulation Study: root mean squared error
To assess the performance of the models in Table 6.1, we used the simulated families
discussed in Section 6.1.1 because the IBD status is known. Using each family, we
predicted the IBD regions using each model. We calculated root mean squared error
(RMSE) using the true IBD status (⇡n) and the predicted IBD status (⇡ˆn) averaged
over all N positions within a given family.
RMSE =
vuut 1
N
NX
n=1
(⇡ˆn   ⇡n)2
After obtaining a family-specific RMSE estimate for each model, we averaged across
the families to compare the models. First, we assessed the RMSE using emission
probabilities which did not vary as a function of MAF (Figure 6.4). The figure shows
Models C and D which use a first-order HMM with conditional emission probabilities
using the IBD status 2 {0, 1, 2} has the smallest root MSE.
Next, we assessed the root MSE using emission probabilities as a function of MAF
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Figure 6.6 : A comparison of RMSE estimates (averaged over 100 simulated families)
using the four models described in Table 6.1 without varyng MAF.
(Figure 6.5). We obtained MAF information from wANNOVAR for 100 families. In
this case, figure shows Models C and D again has the smallest root MSE.
Table 6.3 contains the mean RMSE estimates for the models in Table 6.1 when
considering MAF and not considering MAF in the emission probabilities.
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Figure 6.7 : A comparison of root MSE estimates (averaged over 100 simulated fam-
ilies) using the four models described in Table 6.1 varying MAF.
6.6.2 Visualizing regions of IBD
All inhomogeneous HMMs listed in Table 6.1 were tested using a set of exome sequenc-
ing data for a simulated family introduced in Section 6.1.1. The Viterbi algorithms
were implemented and results for Chromosome 1 in a given simulated family are re-
ported in Figure 6.8. The Viterbi predictions from Models C and D (in pink) most
accurately predict the true IBD status (in black).
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Figure 6.8 : Viterbi predictions for Chromosome 1 from a simulated family: True IBD
status (black), Rodelsperger Model predictions (red), Model A predictions (blue),
Model B predictions (green), Models predictions C and D (pink).
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Table 6.3 : A comparison of mean RMSE estimates (averaged over 100 simulated
families) using the four models described in Table 6.1 without considering MAF.
Rodelsperger Model Model A Model B Models C and D
No MAF varying 0.2256 0.2202 0.2281 0.1730
MAF varying 0.2250 0.2256 0.2262 0.2131
The marginal posterior probability of being an IBD=2 region is given in Figure
6.9. The marginal probability of being in an IBD = 2 regions from Models C and
D (in pink) follows more closely the true IBD status (in black). Model B (second-
order HMM) results a finer structure of the marginal probability of being in an IBD
= 2 region than compared to the other HMMs. At the positions where the HMMs
disagree, the genotypes of the two siblings were checked to see if a di↵erence in the
genotypes between the siblings were causing the finer structure in the second-order
HMM. There did not seem to be any correlation between where the HMMs di↵ered
in their marginal posterior probabilities and where the genotypes di↵ered between
siblings.
6.7 Applications to human exome sequencing data
The inhomogeneous HMMs were tested on a pair of siblings from an acute lymphoblas-
tic leukemia family. We compared the inhomogeneous first-order HMM developed
[Ro¨delsperger et al., 2011] to Models A, B, C and D.
The Viterbi predictions for chromosome 1 (cM) predicting the IBD = 2 regions in
the two siblings from the acute lymphoblastic family are shown in Figure 6.10. The
marginal probability of being an IBD = 2 region is given in Figure 6.11. As there true
IBD status is not known, we cannot compare the Viterbi predictions to the known
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Figure 6.9 : Marginal posterior probability of being IBD = 2 in Chromosome 1 using
a simulated family: True IBD status (black), Rodelsperger Model probability (red),
Model A probability (blue), Model B probability (green), Models probability C and
D (pink).
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Figure 6.10 : Viterbi predictions for Chromosome 1 from an acute lymphoblastic
leukemia family: Rodelsperger et al. (2011) Model predictions (red), Model A pre-
dictions (blue), Model B predictions (green), Models predictions C and D (pink).
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IBD status.
6.8 Discussion
In this chapter we considered several inhomogeneous HMMs to predict regions of IBD
using whole-exome sequencing data. We extended a previously developed first-order
HMM to a first-order HMMwith conditional emission probabilities and a second-order
HMM to explore the second-order dependence structure between the observed variant
calls in siblings. We also showed the emission probabilities used in the HMMs vary
as a function of minor allele frequency. Interestingly, using MAF does not increase
the accuracy of the HMMs.
We considered additional HMMs such a second-order HMM with conditional emis-
sions defined using the IBD status IBD = 2, IBD 6= 2 and IBD 2 {0, 1, 2}. For these
models, we did derive an second-order iterative Viterbi-type algorithm (similar to the
one developed in Section 6.3). The joint distribution of X and ⇡ is then given by
P (X, ⇡) = P [X|⇡]P [⇡] = EL⇧L
= E1⇧1
LY
n=2
P [Xn|Xn 1, ⇡n, ⇡n 1]P [⇡n|⇡n 1, ⇡n 2]
= E1⇧1
LY
n=2
e(Xn 1,⇡n,⇡n 1)(Xn)P⇡n,⇡n 1,⇡n 2
where e(Xn 1,⇡n,⇡n 1)(Xn) is a conditional emission probability for the nth position and
P⇡n,⇡n 1,⇡n 2 is the transition probability at the nth step given the two previous steps.
The general steps for this second-order iterative Viterbi algorithm were as follows.
Let
v⇡0(⇡1, ⇡0) = E1⇧1 = P [X1|⇡1, ⇡0]P [⇡1|⇡0]P [⇡0]
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Figure 6.11 : Marginal posterior probability of being IBD = 2 in Chromosome 1 from
an acute lymphoblastic leukemia family: Rodelsperger et al. (2011) Model probability
(red), Model A probability (blue), Model B probability (green), Models probability
C and D (pink).
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then for n = 1, . . . L  1,
v⇡n(⇡n+1, ⇡n) = P [Xn+1|Xn, ⇡n+1, ⇡n] max
⇡n 1
{ P [⇡n+1|⇡n, ⇡n 1]⇥ v⇡n 1(⇡n, ⇡n 1) }
and for n = L,
v⇡L(⇡L) = max⇡L 1
{ v⇡L 1(⇡L, ⇡L 1) }
giving the final maximization
max
⇡
P (X, ⇡) = max
⇡L
{ v⇡L(⇡L) }
This model was not comparable in accuracy, so we excluded it from the results in this
thesis.
We also considered computing the conditional emission probabilities using an pre-
viously developed approach [Albrechtsen et al., 2009, Han and Abney, 2011] which
was developed for dense genotype data. The goal was to incorporate LD in IBD pre-
dictions. We faced several di culties with this approach including the requirement
of having haplotype frequencies to compute the conditional emission probabilities.
Therefore, we decided to use a simulation-based approach and empirical frequencies
to estimate the emission probabilities used in this thesis.
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Chapter 7
Conclusions
In this thesis, I have developed probabilistic models in application for genetic and ge-
nomic data containing missing or unobservable information. In particular, I focused
on mixture models and hidden Markov models which are used to make inference on
unobserved information using some observed information. The main contributions
of this thesis are the development of two probabilistic models: (1) a mixture model
to estimate a unified posterior probability of functionality of missense mutations dis-
cussed in Chapter 4 and 5 and (2) a HMM to identify co-inherited regions in the
exomes of related individual discussed in Chapter 6.
I briefly introduced mixture models and hidden Markov models in Chapter 2 and
gave several examples of applications since the late 1960s and early 1970s. These
models have frequently been estimated using the Expectation-Maximization (EM)
algorithm. This method was introduced in Section 2.2 including how to estimate
confidence intervals using the estimates from the EM algorithm. I briefly discussed the
genetic architecture of diseases in Section 2.5. While Mendelian diseases are influenced
by low-frequency high-risk variants, common diseases also have been argued to be
caused by rare variants (CDRV hypothesis) with low to moderate e↵ect sizes or by
common variants (CDCV) with moderate e↵ect sizes. Identifying these rare variants
in Mendelian or common diseases is a di cult task. This thesis introduces new
methods to identify the regions containing these disease mutations and to characterize
the mutations found in the region before biological studies are performed (such as
152
functional assays).
Predicting the impact of missense mutations on protein function is an important
factor in identifying and determining the clinical importance of disease susceptibility
mutations. In Chapter 3, we performed a study investigating how functional predic-
tions of missense mutations vary between using di↵erent in silico methods, and also
vary using di↵erent protein sequence alignments. I showed that many computational
or in silico methods have been developed to predict the functionality of missense mu-
tations, but surprisingly there is a high degree of disagreement among the predictions
produced by these methods even though the majority of these methods base their pre-
dictions on similar information (the use of evolutionary conservation as a measure of
pathogenicity). This causes a great di culty to researchers who use these algorithms
as a way of filtering for mutations of interest from next-generation sequencing data
because they will get di↵erent sets of final candidate variants based on employing
di↵erent algorithms and sequence alignments. I showed that even when considering
the same sequence alignment, the algorithms may make di↵ering predictions. I note
that Section 3.1 essentially contains the same information as the paper we published
in Human Mutation [Hicks et al., 2011] which was recently highlighted and discussed
in Nature [Baker, 2012]. From this study, I reviewed possible reasons for the disagree-
ment between predictions of functionality and provide an example of the degree of
disagreement in Section 3.2.
Another approach of identifying mutations impacting protein function may be to
use hidden Markov models to gain position specific information about the function-
ality of missense mutations. Currently, these algorithms make predictions at each
mutation of interest independently and do not consider the functionality of surround-
ing mutations. If an algorithm predicts a mutation as deleterious at a given position,
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then it may be in a functionally relevant portion region of the gene that is evolution-
ary conserved. Given the first mutation was predicted to be deleterious, it is expected
that a second mutation very close to the first would also be predicted deleterious while
a second mutation farther way would be less correlated with the functionality of the
first mutation.
As future work, I would like to investigate this novel idea of using inhomogenous
first-order HMMs to make inference on the true functionality of missense mutations
using the observed predictions from the bioinformatic algorithms (e.g. PolyPhen-2,
SIFT). The idea is to model the pathogeneticity of mutations along a given gene to
increase sensitivity and specificity of the computational methods because when not
enough information is known about a particular mutation, the HMM may make infer-
ence using the information known about a mutation within a close distance on a given
gene if available. The goal would be to predict the unobserved true functionality of
the mutation as either truly neutral or truly deleterious given the observed functional
predictions. I believe this approach could increase the sensitivity and specificity of
the predictions by using inhomogeneous transition probabilities at each mutation that
account for the distance between the mutations in a given gene. Using the notation
defined in Section 1.1.3, the true functionality status would be provided by the unob-
servable Markov chain ⇡n and the observed predictions from a given computational
method would be given by Xn.
One of the barriers to this approach is the lack of ‘gold standard’ for this type of
data. There is lack of exome-scale set of missense mutations with known functional
impact on protein function. One reason is that the functionality of exomic data is
not known a priori so we would not able to directly compare sensitivity and speci-
ficity values for the PolyPhen-2 predictions and Viterbi predictions. Another great
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challenge is how to create a standardized approach that can use any of the existing
bioinformatic algorithms semi-automatically on either the well-characterized sets of
mutations or mutations called from exome sequencing.
Because the functional predictions from available in silico methods often have a
high degree of disagreement, we developed a mixture model which estimates a unified
posterior probability of functionality or pathogenicity. In Chapter 4, two statistical
models based on the capture-recapture paradigm were developed which combine the
discordant functional predictions in a statistically rigorous manner. Our models esti-
mate a unified posterior probability of functionality or pathogenicity for each missense
mutation. Unlike previous methods, our probabilistic approach requires no training
set or calibration and estimates the accuracy (sensitivity and specificity) of each indi-
vidual in silico method in the absence of a gold standard by taking advantage of the
fact these methods disagree. Compared to previous attempts to combine predictions
of functionality which weight the predictions by normalized scores or allele frequencies,
our approach weights the functional predictions by the estimated accuracy of each
method. In Section 4.2 the two models referred to as postMUT and postMUT (sim-
ple) were introduced and the parameter estimates for the Expectation-Maximization
algorithm were derived. In Section 4.3 we showed our estimates of sensitivity and
specificity of the in silico algorithms (without employing a gold standard) match the
estimates of sensitivity and specificity when a gold standard is available. The poste-
rior probability of pathogenicity introduced in this chapter is a statistical tool scalable
to the exome which may be used to infer the functionality of missense mutations and
can be easily incorporated in downstream analyses such as disease gene prioritization
tools ultimately inferring candidate genes.
In Chapter 5, we performed a set of simulations assessing the bias and mean
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squared error of the parameter estimates from our postMUT (simple) and postMUT
models. We considered various scenarios such as varying the sensitivity and specificity
of each in silico algorithm and varying the number of algorithms considered. This
is important because the posterior probabilities weight the functional predictions
based on the accuracy of each algorithm. We showed how the confidence regions of
the sensitivity and specificity estimates vary depending on the overall proportion of
deleterious mutations in set considered.
In Chapter 6, we developed several hidden Markov models (HMMs) to identify
regions of IBD using the observed IBS status from whole-exome sequencing data.
We considered several extensions of a previously developed first-order inhomogeneous
HMM that identifies regions of IBD in siblings that can be used a filter in search
of finding the casual variant for a given disease. A comparison of the models con-
sidered is given in Table 6.1. We explored the idea of using conditional emission
probabilities (depends on both IBD and IBS status) varying as a function of minor
allele frequency and a second-order HMM which models the second-order dependence
structure between observed variant calls. A non-trivial challenge is how to develop
accurate models for human Mendelian disorders concerning recombination patterns
while accounting for any dependence structure between observed variant calls in re-
lated individuals.
One possible way to improve these HMMs is to estimate the emission probabil-
ities using genotype and haplotype frequencies as opposed to our approach of us-
ing simulation. We did investigate this approach which was previously discussed
[Han and Abney, 2011], but decided on a simulation-based approach because the com-
binatorics quickly became very complicated. For example, one HMM we considered
had 81 di↵erent possible combinations of IBD and IBS states making it almost in-
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tractable to approach from a probabilistic view.
We applied these models to whole-exome sequencing data and showed how these
models can be used to identify disease susceptibility mutations. We assessed the ac-
curacy of the models by simulating whole-exome sequencing data discussed in Section
6.1.1. Using the known IBD status from the simulated families, we were able to com-
pare the root mean squared error from each each model averaged over a set of families.
We showed a first-order HMM with conditional emission probabilities defined using
the hidden IBD status 2 {0, 1, 2} has smaller root mean squared error compared to
the first-order HMM previously developed [Ro¨delsperger et al., 2011]. The second-
order HMM performed comparably to the first-order HMM suggesting a second-order
dependence structure does not increase the accuracy of predicting IBD regions. We
also applied these HMMs to a set a unpublished real human exome sequencing data
in Section 6.7 which was discussed in Section 6.1.2. We predicted regions of IBD on
a pair of siblings in this family with an autosomal dominant disorder.
As disease-gene identification projects increasingly use next-generation sequenc-
ing, the probabilistic models developed in this thesis help identify and associate rel-
evant disease-causing mutations with human disorders. The purpose of this thesis
is to demonstrate that probabilistic models can contribute to more accurate and de-
pendable inference based on genetic and genomic data with missing information.
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